Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Streptococcus pyogenes M1 GAS, SF370

>SPy1595 putative sugar-binding transport protein
MIRQTNKKTSFWKNVIKYRALLLMVLPGFIWFIFFFYIPVLANVVAFKDF
HYSAGGFMESLKESPWVGLANFKYLFASKDAWLITRNTIAYNVIFLLFNV
FFAIAFAIIMSELRNKRTVKVYHTMSLLPYFLSWVVIEYFVSAFLNTDKG
FINQLLTGSGADPIKWYSNPTWWPLILLFMSVWKGLGYNSIIYYASVKGI
SDTYYEAAMVDGASKWQQIRNITIPQLLPMMSILLIINIGNIFKSDFGLF
YVIPKNSGPLYDVTSVLNTYVYNALTATGDIGMASAASLYQSVVGTSILL
VTNAIVRRMDPDAALF
>SPy0855 putative fructose-specific enzyme II, PTS system BC component
MKIQDLLRKDIMILDLQAISKEVAIDEMITKLVEKDIVHDFDVFKKSIMT
REEQTSTGLGDGIAMPHSKNIVVDKPAVLFAKSNKGVDYKALDGQPTDLF
FMIAAPQGANDTHLAALAELSQYLLKDGFADKLRAAATPEAVIAVFDEAS
TAKEEVVAPTSGQDFIVAVTACPTGIAHTYMAEEALKKQAAEMGVAIKVE
TNGASGVANRLTAEDIQRAKGVIVAADKAVEMDRFDGKQFIARPVADGIK
KSQELISLILNNEGNTYHAKNGKSETAVSTEKTSLGGAFYKHLMGGVSQM
LPFVIGGGIMIALAFLLDNMLGVPNDQLGSLGSYHEIAAIFMNIGGAAFS
FMLPVLAGYIAYSIAEKPGLVAGFVAGAIASNGLAFGKVPFAAGGEVSLG
LTGVPSGFLGALVGGFLAGGVILALRKLLAGLPRSLEGVKSILLYPLLGV
LVTGFLMLFVNIPMAAINTALNDFLQGLSGSSAVLMGLLVGGMMAVDMGG
PVNKAAYVFGTGTLAATVANGGSVVMAAVMAGGMVPPLAVFVATLLFKDK
FTKEERESGLTNIVMGLSFITEGAIPFGAADPARAIPSFIAGSALTGALV
GLAGIKLMAPHGGIFVIALTSNPILYLVFVVIGALVSGILFGALRKKA
>SPy1596 putative transcriptional regulator
MRHDRLFYYNKGEHLMSLLCIDIGGTSLKFALCHNGQLSQQSSFPTPSSL
EKFYQLLDQEVARYSAYHFSGIAISSPGAVNKEKGVIEGASAIPYIHHFK
IQEALEERLHYPISIENDANCAALAEATLGAGKGASSLAMLVLGTGVGGS
LVIDGKIYHGAHLFGGEFGFMIMNDRYQTFSQLGTVVNMAKRYSAIVNNG
KDYTGKAVLALAEQGDPLALKERQVFLQSLAIGIFNIQHAFDPQLILIGG
GVSQADFLLSAIEAELDKLYQAVEISDLRPQLAICHFKNEANLLGAAIDF
YQEHKEA
>SPy1247 putative myo-inositol-1(or 4)-monophosphatase
METKYAFARQIIKEAGLFIKSKMSEQLDIQVKTQFDDLVTNVDQETQQLL
MDRIHQTYPCDAILAEENDVRHPINQGNVWVIDPIDGTVNFIVQGSQFAV
MIAYYEQGIGQFGLIYDVMADQLLAGGGDFEVTLNGDKLPAYQEKPLERS
LIGCNAGMFARNDRNLAHLIAKTLGVRVYGGAGICMVKVMKQELLAYFSF
IQPWDYAAAKVLGDKLGYVLLTIDGYEPDFQTRQKIMFVPKCQLTRIASF
LTKDSAITLEDQ
>SPy1060 putative phospotransferase system (PTS), enzyme II component D
MTSQDNLTKEDRKMLRSVFWRSWTMNASRTGATQYHAVGVIYTLLPVINR
FYKTDKDKAEALVRHTTWFNATMHINNFIMGLVASMEKKNSEDPDFDASA
ITAVKASLMGPISGVGDSFFWGILRVIAAGIGISLASAGSAMGAVVFLLL
YNIPAFIIHYYSLYGGYSVGAGFIKKLYESGGIKIVTKTSSMLGLMMVGS
MTASNVKFKTILTVAAKGAKEAASIQDYLDQLFIGIVPLMVTLAAFWLLR
KKVNIIWIMFGIMFLGIILGLLGIC
>SPy2052 putative PTS system, enzyme III
MQVIVPDQIIMGLILNAGDAKQHIYQALKCAKEDDYATSEKEMALADDAL
LEAHNLQTQFLAQEASGNKSEITALFVHSQDHLMTTITEINLIKEIIDLR
KELATK
>SPy1126 conserved hypothetical protein
MTQMNYTGKVKRVAIIANGKYQSKRVASKLFSVFKDDPDFYLSKKNPDIV
ISIGGDGMLLSAFHMYEKELDKVRFVGIHTGHLGFYTDYRDFEVDKLIDN
LRKDKGEQISYPILKVAITLDDGRVVKARALNEATVKRIEKTMVADVIIN
HVKFESFRGDGISVSTPTGSTAYNKSLGGAVLHPTIEALQLTEISSLNNR
VFRTLGSSIIIPKKDKIELVPKRLGIYTISIDNKTYQLKNVTKVEYFIDD
EKIHFVSSPSHTSFWERVKDAFIGEIDS
>SPy1058 putative phosphotransferase system (PTS), enzyme II component B
MITQIRVDDRLIHGQVAVVWTKELNAPLLVVANDEAAKNEITQMTLKMAV
PNGMKLLIRSVEDSIKLFNDPRAKDKRIFVIVNSVKDACAIAKEVPDLEA
VNVANVGRFDKSDPASKVKVTPSLLLNPEEMAAAKELVSLPELDVFNQVL
PSNTKVHLSQLVN
>SPy0603 hypothetical protein
MSAKLMSRIAIMSALCVVLRMVFSSLPNVQPVTAFLLSYLLYFGLAEAVL
VMMLCLFLSAFLLGFGPWVFWQVTCFVLVLLLWRFVLYPLSQQFPKYQLG
CQAFLVALCGLLYGVLIDTCFAYLYSMPWWSYVLAGMPFNIAHALSTLVF
FPVVMMLFRRLIGEQKI
>SPy1710 putative PTS system, enzyme IIB component
MIKILAACGAGVNSSHQIKDAIETQMSDRGYDVHCDAVMVKDITEELVSR
YDIFTPIAKTDLGFEMPIPIVEAGPILYRIPIMSEPVFAELERVIKENHL
Q
>SPy1294 putative maltose/maltodextrin-binding protein
MKSWQKVIVGGASLTLASTLLVGCGSGSKDKKEAGADSKTIKLWVPTGSK
KSYADTIAKFEKDSGYTVKVVESEDPKAQEKIKKDASTAADVFSLPHDQL
GQLVESGTIQEVPEKYNKEIAATSTDQALVGAQYKGKTYAFPFGIESQVL
FYNKSKLAAEDVTSYDTITTKATFGGTFKQANTYATGPLFMSVGNTLFGE
NGEDVKGTNWGNEKGAAVLKWIADQASNKGFVSLDANNVMSKFGDGSVAS
FESGPWDYEAAQKAIGKENLGVAIYPKVTIGGETVQQKAFLGVKLYAVNQ
APAKGDTKRIAASYKLASYLTNAESQENQFKTRNIVPANKEVQSSEAVQS
NELAKTVITMGSSSDYTVVMPKLSQMGTFWTESAAILSDAFNGKIKENDY
LTKLQQFDKDIAATK
>SPy0176 conserved hypothetical protein
MNLKQAFIDNNSIRLGLSADTWQEAVRLAVQPLIDSKAVTSAYYDAIIAS
TEKYGPYYVLMPGMAMPHAEAGLGVNRNAFALITLTKPVTFSDGKEVSVL
LTLAATDPSIHTTVAIPQIVALFELDNAIERLVACQSPKEVLEMVEESKD
SPYLEGMDLNA
>SPy0572 beta-glucoside permease IIABC component
MTYQETAKAILAAVGGKTNIQRVTHCVTRLRLVLKNDEKVKDQQVKAISN
VIGVMRKNGQYQIILGNDVNNYYQAFLSLGHFDNQDEDHSSKAKGSILER
LIETIAGVITPLIPALLGGGMLKVVGILLPMLGLASADSQTVAFINFFGD
AAYYFMPVMIAYSAAARFKVTPVLAATIAGILLHPAFVAMVAEGKPLTLF
GAPVTPASYGSSVIPILMMVYLMQYIEKWVNRLVPSVMKSFLQPTLIILI
SGFLALVVVGPLGVIIGQGLSNTMLAIYHVAPWLALAILGAIMPLVVMTG
MHWAFAPIFLAASVATPDVLILPAMLASNLAQGAASLAVAFKTKQKQTRQ
VALAAGISALLAGITEPALYGVTLKFKKPLYAAMISGGLVGAFIGFVNIA
SYTFVVPSIIGLPQYINPSGGANFTNALIAGTATIVLAFSLTWFMGIDEE
SPKQVSVAADMSQVKSGLSTKQTLYAPMTGEMLFLSEVPDETFSSKLLGE
GFAILPSEGEVYAPFDGEVITFFPTKHAVALKNTRGVEVLIHVGIDTVEL
KGQGFEQLVSVGDVVKRGQALLKMDIDFITSKGYSLISPVVVTNSAEQLE
IIIQDDKKMVTKEDALLVIL
>SPy2050 putative PTS system, enzyme IIC component
MAKMNMQNIIKPIMTFVNMRGIIALKDGMLAILPLTVVGSLFLIAGQIPF
QGVNDAIASVFGADWTEPFMQVYHGTFAIMGLISCFAIGYSYAKNSGVEP
LPSGVLSLSAFFILLRSSYVPAEGEAIGDAISKVWFGGQGIIGAIVIGLT
VGAVYTTFIRRHIVIKMPDQVPQAIAKQFEAMIPAFVIFTLSMLVYIIAK
SVTGGGTFIEMIYDVIQVPLQGLTGSLYGALGIAFFISFLWWFGVHGQSV
VNGIVTALLLSNLDANKALMAAGELSLDKGAHIVTQQFLDSFLILSGSGI
TFGLVVAMIFAAKSKQYKALGKVAAFPALFNVNEPVVFGFPIVMNPVMFL
PFILVPVLAALTVYGAIAIGFMQPFAGVTLPWSTPAIISGFMVGGWQGAI
VQILILIMSTLVYFPFFKIQDNMAYQNEQASEES
>SPy0254 sugar transport system (permease)
MHMSNGHWKEAFLFRKVEQKKEVFQVNVNKLKMRETLISYAFLAPVLVFF
VIFVLIPMIMGFVTSFFNYSMTEFTFVGFANYARMFQDPIFMKSLINTLI
IVIGSVPVVVFFSLFVAAKTYDKNVVARSFYRAVFFLPVVTGSVAVTVVW
KWIYDPMSGILNYVLKYAHVIEQNISWLGDKHWALLAIIVILLTTSVGQP
IILYIAAMGNIDNSLVEAARVDGATEFQVFWNIKWPSLLPTTLYIAVITT
INSFQCFALIQLLTSGGPNYSTSTLMYYLYEKAFKLSEYGYANTMGVFLA
VMIAIISFAQFKILGNDVEY
>SPy0543 putative efflux protein
MNNRKKNIQYLVYSKVIYRIGDVMFDFANNTFLAGLNPASLSLVAVYQSL
ESVIGVLFNLFGGVIADSFKRKKIIITTNILCGTACLVLSFLTKEQWLVY
AIVLTNVILAFMSAFSSPSYKAFTKEIVKKDSISQLNSLLETTSTVIKVT
VPMVAIFLYKLLGIHGVLLLDGLSFLIAALLISFILPVNDEVVIKEKVTI
REIFNDLKIGFKYVYSHKSIFIITVLSALVNFFLAAYNLLLPYSNQMFGE
ISTGLYGTFLTAEAIGGFIGAILSGFVNKELSSMRLILFLSLSGLMLMLA
PPFYIMFHNAIILALSPALFSLFLSIFNIQFFSLVQKDVDNDFLGRVFGI
IFTITILFMPIGTGFFSVALNPNNSFNLFIIGSCITTLSLVFRILFKKYN
IR
>SPy1043 conserved hypothetical protein
MPYKGYLIDLDGTIYQGKNRIPAGERFIKRLQERGIPYLLVTNNTTRTPE
MVQSMLANQFHVETSIETIYTATMATVDYMNDMNRGKTAYVIGETGLKSA
IAAAGYVEELENPAYVVVGLDSQVTYEMLAIATLAIQKGALFIGTNPDLN
IPTERGLMPGAGALNALLEAATRVKPVFIGKPNAIIMNKSLEVLGIQRSE
AVMVGDNYLTDIMAGIQNDIATILVTTGFTRPEEVPTLPIQPDHVLSSLD
EWRL
>SPy0442 putative glycerol-3-phosphate transporter
MEEDYNKREPEKFTQFLRRQKVVFFVAFFGYVCAYLVRNNFKLMSNTIMV
QNGWDKAQIAILLSCLTVSYGLAKFYMGALGDRVSLRKLFSISLGASALI
CILIGFFNSSMVVLGILLVLCGVVQGALAPASQAMIANYFPNKTRGGAIA
GWNISQNMGSALLPLTIALLTSMGLVVPANGNILLAFLIPGVLVFLFALC
CWKLGGDNPESEGLDSLRTMYGDAGESAVASEEEKHNLSYWQLIWKYVFC
NPSLLLVAAVNVALYFVRFGIEDWMPIYLSQVANMSEAHIHFAISMLEWV
AIPGSLVFAWLAVRYPNKMAKVGAIGLFVLAAIVFVYERLTATGAPNYFL
LLVIAGILGSLIYGPQLIVNILTINFVPLNVAGTAIGFVGVTAYLIGNMG
ANWLMPILADGFGWFWSYIVVAALSAFSAVGYLILAKREEEIIKD
>SPy1586 putative beta-galactosidase
MVYRQKSSEIVTRTITKPSRATSNVKQEIDMTPDSKEQTVTGYQYHYIDQ
EGRKQPFNQGWRFLMADVACAQDPSFDDSNWQVIHLPHDFSLTQPYTRNG
EAESAYKLGGVGWYRHYLVLDEVLAGCHVAITFEGSYMETEIYVNGQFIG
KHLNGYQEFTYDISDVVTFGAENLLAVRVENKVPSSRWYSGSGLYREVSL
SVLPQLHFVADQVAMTLADTAVQEKGQQKVDLRFALNQSIQTCHYQLSLC
LWEQSHCSKDKKLLYQETEVPLADLAFQRQYGLTLSLEELQLWSPDNPHL
YDLELTLYYQGQVIDCFCLETGFRQLTFMANQGLFVNGRAVKLKGVCLHH
DQGGLGACAYEDALARQLVLLKDMGANTIRSTHNPSSPKLRQLANRLGFF
VIEEAFDTWTYAKNGNVNDFSNYFHQTIGTENANYLQRVRSPETSWAQYS
IEAMVWSAKNDPSVLMWSIGNELMEGFSADVSHYPELTRQMCQWITAIDT
SRPITFGDNKLKEADFCWHEEVSQMATLLSQLDHPQGLIGLNYADGKDYD
RLHEEHSDWLLYGSETVSAITSRAYYKETKKVLDSGYHLTSYDHAKVDWG
AFASQAWYDTITRDFVAGECVWTGFDYLGEPTPWNKIDSGVVGLWPSPKN
AYFGILDTAGFPKDSYYFYQSQWAQGQTTLHLLPVWQKDQLCFDEQGLVE
VVVYSNAASVQLMFEDEQGNLTDYGRKAFHTYSTPTGHTYQLYQGADAAK
NPHENLYLTWRVPYQKGLLRAVAYDISGKSIPKTSGRSQVRTYGSVAKLS
WKAFEAPIDAPWELLYLDLSLLDSRGELVSHAQDWLQVQVEGPARLLALD
NGNPTDHTPYQEPLRQAYGGKLLAILALTGEAGHIKVTAKASQQLSSVFQ
TQVACRAPKEHLVTLPLEKYQFKKSRLTSQQEIGQSCLKTTQFLSVLENK
DTQQKAGKASTPHILITSYQHYLSLPLQVCSQAFDFKKGDDIFLPQWLQV
KDAQGSLVKKAFSMTWYLKEKIFAKPILVTGYVSCFGQSIPVEARLNLAQ
ASKRRHQDLSLVAKQSLAASQKRLTYCYQYDTVQAIGAISLQNHTGTSLS
VSVAISYGSQSSIKQETLMLADSHLSQLEEVIFFDDILTVLYLAVTLEVI
EGPDLTEDSIQIGLWDLA
>SPy0255 probable sugar transport protein (permease)
MTKKKLTASDILTTVMLCVLTILFIFPFYWIMTGAFKAQADTIMIPPQWW
PKAPTIENFKALVVQNPALKWLWNSVFISVATMFLVCGTSSLAGYALAKK
RFYGQRLLFSIFIAAMALPKQVVLVPLVRIVNFMGIHDTLAAVILPLVGW
PFGVFLMKQFSENIPTELLESAKIDGCGEIRTFFNVAFPIVKPGFAALAI
FTFINTWNDYFMQLVMLTSRENLTISLGVATMQAEMATNYGLIMAGAAMA
AVPIVTVFLVFQKSFTQGITMGAVKG
>SPy1599 putative beta-glucosidase
MLAFPKEFWWGGATSGPQSEGRFAKQHRNLFDYWYEEEPDLFYDYVGPDT
ASDAYHQIESDLTLLASLGHNSYRTSIQWTRLIDDFEQATINPDGLAYYN
RVIDACLANGIRPVINLHHFDLPIALYQAYGGWESKHVVDLFVAFSKVCF
EQFGDRVKDWFVHNEPMVVVEGSYLMQFHYPAIVDGKKAVQVAYNLALAT
AKVIQAYRRGPAELSDGRIGTILNLTPAYPASQSEADMAAAHFAELWNND
LFMEAAVHGKFPEELVAVLKKDGVLWQSTPEELALIAENRVDYLGLNFYH
PKRVKAPDAIPVISPSWSPEWYYDPYLMPGRRMNVDKGWEIYPEAVYDIA
IKMRDHYDNIPWFLSENGVGISGEDRYRDETGQIQDDYRIQFLKEHLTYL
HKGIEAGSNCFGYHVWTPIDGWSWLNAYKNRYGLVENNIHTQVRRPKASA
YWFKKVATHNRLISLEVMEEFGGSASHLSD
>SPy0535 hypothetical protein
MTFHITVNLDEISDKLDDSLKFLNRLSIKSCELRMINTKNIIQLSDAELI
NLKERLQKYNITPISIASPLFKWNIEENHLESNLDLYGISANVTLNEQWL
YVRKIIFIAKFLNIKYVRIFGGIGCSVDDFLNNELFLNLLKETEIIFLIE
NELGTSVSTADDLLKIGHFIDEKSIKNLKIWFDIANYYIVEPQVDKVIPK
LKKYIYYIHCKNYVNNDLGIHYVELGKGIIDYKTIIHEIHEHFIDLIFSL
EVHEKEIDKKAEVVRKSYLTLNEYINGG
>SPy1392 putative oxalate:formate antiporter
MEKTKRYIIATAGILLHLMLGSTYAWSVYRNPILQETGWDQAPVAFAFSL
AIFCLGLSAAFMGNLVEQYGPRLTGTVSAILYASGNMLTGLAIDRKEIWL
LYIGYGVIGGLGLGAGYITPISTIIKWFPDKRGMATGFAIMGFGFASLLT
SPIAQWLIETEGLVATFYLLGLIYLIVMLFASQLIIKPTAAEIAILDKKR
LQNNSYLIEGMTAKEALKTKSFYCLWVILFINITCGLGLISVVAPMAQDL
TGMSPEMSAIVVGAMGIFNGFGRLVWASLSDYIGRRVTVILLFLVSIIMT
ISLIFAHSSLIFMISIATLMTCYGAGFSLIPPYLSDLFGAKELATLHGYI
LTAWAIAALTGPMLLSITVEWTHNYLLTLCVFIVLYILGLMVALRLKK
>SPy0637 sugar-phosphate isomerase
MKIALINENSQAAKNGIIYDALTTVTDKHGYQVFNYGMYGTEGESQLTYV
QNGLLASILLTTKAADFVVTGCGTGVGAMLALNSFPGVTCGFASEPTEAY
LFSQINGGNALSIPFAKGFGWGAELNLTLIFERLFAEPMGGGYPKERAIP
EQRNARILSDLKKITYRDLLAIVKDIDQDFLKETISGAHFQEYFFANAEP
SELVTYLKSVLEQ
>SPy1950 conserved hypothetical protein
MIKIVTVCGNGIGSSLLLRMKVEAIASSLGIDVDAESCDSNAAVGKGADL
FVTVKEFKDIFPEDAKVCIVKSYTNRKKIEEDLVPVLKEMSGKE
>SPy0095 putative histidine triad (HIT) protein
MTECIFCHQLKANQLLTQSQYFKVVFDIDPIQKGHLLLISKDHYTSLTQL
PKEGHYDLIDLQAALVAKLEQHLPISGVTSVSNDKELMDEGTHFHLHLIP
RLTNDSFWEGITINQENWDLTPFLKHL
>SPy0146 putative regulatory protein
MDIIIGTSLLILVLAIFSLFNYKAPHGAKAMGALASAACASFLVEAFQDS
FFGKVLGFQFLSEVGGANGSLSGVAAAILVAIAIGVSPGYAVLIGLSVSG
TGIIPGFVAGYVVSFLIKWMEKNIPGGLDLISIIIVGAPLTRFLAQLITP
VINSTLLTIGDILTSSANSNPIIMGMILGGTIVVVATAPLSSMALTAMLG
LTGIPMAIGALSVFGSSFMNGVLFYRLKLGERKDNIAFAIEPLTQADVTS
ANPIPIYVTNFVGGAACGVLIALMKLVNDTPGTATPIAGFAVMFAYNPVA
KVLITALGCIIISLIVGYIGGSVFKNYRLVTKQELQARN
>SPy2205 conserved hypothetical protein
MFTWGSIGFVSNKIGGKPSQQTLGMTFGALLFSLAVWLIVRPEMTLQLWL
FGILGGFIWSIGQTGQFHAMQYMGVSVANPLSSGSQLVLGSLIGVLVFHE
WTRPMQFVVGSLALLLLIVGFYFSSKQDDANAQVNHLHNFSKGFRALTYS
TIGYVMYAVLFNNIMKFEVLSVILPMAVGMVLGAITFMSFKISIDQYVIK
NSVVGLLWGIGNIFMLLAASKAGLAIAFSFSQLGAIISIVGGILFLGETK
TKKEMRWVVTGIICFIVGAILLGVVKS
>SPy1604 conserved hypothetical protein
MATKKVHIISHSHWDREWYMAYEQHHMRLINLIDDLLEVFQTDPDFHSFH
LDGQTIILDDYLKVRPEREPEIRQAIASGKLRIGPFYILQDDFLTSSESN
VRNMLIGKEDCDRWGASVPLGYFPDTFGNMGQTPQLMLKAGLQAAAFGRG
IRPTGFNNQVDTSEKYSSQFSEISWQGPDNSRILGLLFANWYSNGNEIPT
TEAEARLFWDKKLADAERFASTKHLLMMNGCDHQPVQLDVTKAIALANQL
YPDYEFVHSCFEDYLADLADDLPENLSTVQGEITSQETDGWYTLANTASA
RIYLKQANTRVSRQLENITEPLAAMAYEVTSTYPHDQLRYAWKTLMQNHP
HDSICGCSVDSVHREMMTRFEKAYEVGHYLAKEAAKQIADAIDTRDFPMD
SQPFVLFNTSGHSKTSVAELSLTWKKYHFGQRFPKEVYQEAQEYLARLSQ
SFQIIDTSGQVRPEAEILGTSIAFDYDLPKRSFREPYFAIKVRLRLPITL
PAMSWKTLALKLGNETTPSETVSLYDDSNQCLENGFLKVMIQTDGRLTIT
DKQSGLIYQDLLRFEDCGDIGNEYISRQPNHDQPFYADQGTIKLNIISNT
AQVAELEIQQTFAIPISADKLLQAEMEAVIDITERQARRSQEKAELTLTT
LIRMEKNNPRLQFTTRFDNQMTNHRLRVLFPTHLKTDHHLADSIFETVKR
PNHPDATFWKNPSNPQHQECFVSLFDGENGVTIGNYGLNEYEILPDTNTI
AITLLRSVGEMGDWGYFPTPEAQCLGKHSLSYSFESITKQTQFASYWRAQ
EGQVPVITTQTNQHEGTLAAEYSYLTGTNDQVALTAFKRRLADNALITRS
YNLSNDKTCDFSLSLPNYNAKVTNLLEKDSKQSTPSQLGKAEILTLAWKK
Q
>SPy1766 putative phosphoglycerate mutase
MTKTRLYIARHGKTMFNTIGRAQGWSDTPLTKKGEEGIRELGLGLKDATI
PFKAAFSSDSGRTMQTIEIILRESENEFLPYTKDNRIREWCFGSLEGTYD
SELFLGVLPRTKAFENRDNLRDVPYSELAESIVEVDTANWAEPWEVLRKR
IWEGFEAIALSIQNAGGGNALVVSHGMTIGTFLWLIDPDRDKQYIDNGSV
TVVEFDDGQFTIKTIGDMSYRYRGREIIEERSDEI
>SPy1813 hypothetical protein
MDKHLLVKRTLGCVCAATLMGAALATHHDSLNTVKAEEKTVQVQKGLPSI
DSLHYLSENSKKEFKEELSKAGQESQKVKEILAKAQQADKQAQELAKMKI
PEKIPMKPLHGSLYGGYFRTWHDKTSDPTEKDKVNSMGELPKEVDLAFIF
HDWTKDYSLFWKELATKHVPKLNKQGTRVIRTIPWRFLAGGDNSGIAEDT
SKYPNTPEGNKALAKAIVDEYVYKYNLDGLDVDVEHDSIPKVDKKEDTAG
VERSIQVFEEIGKLIGPKGVDKSRLFIMDSTYMADKNPLIERGAPYINLL
LVQVYGSQGEKGGWEPVSNRPEKTMEERWQGYSKYIRPEQYMIGFSFYEE
NAQEGNLWYDINSRKDEDKANGINTDITGTRAERYARWQPKTGGVKGGIF
SYAIDRDGVAHQPKKYAKQKEFKDATDNIFHSDYSVSKALKTVMLKDKSY
DLIDEKDFPDKALREAVMAQVGTRKGDLERFNGTLRLDNPAIQSLEGLNK
FKKLAQLDLIGLSRITKLDRSVLPANMKPGKDTLETVLETYKKDNKEEPA
TIPPVSLKVSGLTGLKELDLSGFDRETLAGLDAATLTSLEKVDISGNKLD
LAPGTENRQIFDTMLSTISNHVGSNEQTVKFDKQKPTGHYPDTYGKTSLR
LPVANEKVDLQSQLLFGTVTNQGTLINSEADYKAYQNHKIAGRSFVDSNY
HYNNFKVSYENYTVKVTDSTLGTTTDKTLATDKEETYKVDFFSPADKTKA
VHTAKVIVGDEKTMMVNLAEGATVIGGSADPVNARKVFDGQLGSETDNIS
LGWDSKQSIIFKLKEDGLIKHWRFFNDSARNPETTNKPIQEASLQIFNIK
DYNLDNLLENPNKFDDEKYWITVDTYSAQGERATAFSNTLNNITSKYWRV
VFDTKGDRYSSPVVPELQILGYPLPNADTIMKTVTTAKELSQQKDKFSQK
MLDELKIKEMALETSLNSKIFDVTAINANAGVLKDCIEKRQLLKK
>SPy1593 putative sugar-binding transport protein
MEKKKKVEKVNVRTFDRKTNAIFNILIGLFAISCIIPFIFVIIISFTDES
YLINHGYSFFPDVWSTKAYQYIFQGAMSHRIMRSFGISVFITVVGTFINT
TMTSTYAYAISRPYFPYRRFFTVYALITMLFAPGMVANYLVVSNLLHLKD
TVWALILPMALGPFGILVMRTFFKKTVPDSIIESARMDGASEWMIFMKIV
LPLAVPGIATISLFSALTYWNDWFNALLYVQSENLYPMQYLLMKIQSNLQ
ALAQNAGMSAQMADSLASLPKESVRMAIVVIATLPIALTYPFFQKYFVGG
LTIGGVKE
>SPy0570 putative drug resistance protein
MSHHQQTVSKQTIMAIIAIALIGFSGILSETSMNVTFPTLMSVYQLPLNS
LQWMTTIYLLAVAIMMTTSATLKKNVRERPLFFMATGLFTFGTILAVLTQ
SFAIMLLARIFQGIGTGLVMPQMFNIILERVPMHKVGLFMGFAGLIISLA
PAFGPTYGGFMISHFSWQWIFICILPVPLIAGILAYYYLEDSPVSEKVPF
DWLAFIALSISLTSALLAITSLENGSVNLYYLGLFILSFILFLYKNLTAK
QPFLDIRILKIPSLTFGLIPFFVFQLINLGINFLTPNFIVMEKIANSSQA
GMVLLPGTLLGALLAPAFGKLYDQKGARLSLYLGNALFSLSLIIMTLQTR
HFMLLPFTLLYILFTFGRNMGFNNSLATAIRELPAEKNADATAIFQMMQQ
FAGALGTAMASLIANSQAEFTSGVQSVYLLFTIFALLDFIFFFAMFYHLG
KKGLA
>SPy0175 conserved hypothetical protein
MVKVLTACGNGMGSSMVIKMKVENALRQLGVTDIQSASCSVGEAKGLASG
YDIVVASNHLIHELDGRTKGHLVGLDNLMDDNEIKTKLQEVL
>SPy1059 putative phospotransferase system (PTS), enzyme II, component C
MAALAVLICFGGNYLTGQSMMERPLVVGLVTGLLLGDMKVGILMGASLEA
LFLGNVNIGGVIAAEPVTATAMATTFTIISHIDQKAAMTLAVPIGMLAAF
VVMFLKNVFMNIFAPMVDKAAAANHQGKLVMLHYGTWIIYYLIIASISFI
GILVGSGPVNAFVEHIPQNLMNGLSAAGGLLPAVGFAMLMKLLWTNKLAV
FYLLGFVLTAYLKLPAVAVAALGAVICVISSQRDLELDAITRGAISKQTT
FDSKESEEEDFFA
>SPy0178 putative hexulose-6-phosphate isomerase
MARPIGIYEKATPKQFTWRERLQFAKDLGFDFVEMSVDESDARLARLEWT
KEERLDLVKAIYETGIRIPTICFSGHRRYPLGSNDPAIEAKSLKLMKQCI
ELAQDLGVRTIQLAGYDVYYEKKSPETRARFIKNLRQSCDWAEEAQVMLS
IEIMDDPFINSIEKYLAVEKEIDSPYLFVYPDAGNVSAWHNDLWSEFYNG
HKSIAALHLKDTYAVTETSKGQFRDVPFGQGCVDWQELFAVLKKTNYNGP
FLIEMWSENCDTVEETKAAIKEAQDFLYPLIEKAGLT
>SPy1678 putative transaldolase
MKFFLDTANVAAIKAINELGVVDGVTTNPTIISREGRDFETVIKEICDIV
DGPISAEVTGLTADAMVEEARSIAKWHDNVVVKIPMTTEGLKATNILSKE
GIKTNVTLIFTVSQGLMAMKAGATYISPFIGRLEDIGTDAYQLISDLREI
IDLYDFQAEIIAASIRTTAHVEAVAKLGAHIATIPDPLFAKMTQHPLTTN
GLKTFMEDWASFKK
>SPy0252 putative sugar transporter sugar binding lipoprotein
MNMKKLASLAMLGASVLGLAACGGKSQKEAGASKSDTAKTEITWWAFPVF
TQEKAEDGVGTYEKKLIAAFEKANPEIKVKLETIDFTSGPEKITTAIEAG
TAPDVLFDAPGRIIQYGKNGKLADLNDLFTEEFTKDVNNDKLIQASKAGD
TAYMYPISSAPFYMALNKKMLKDAGVLDLVKEGWTTDDFEKVLKALKDKG
YNPGSFFANGQGGDQGPRAFFANLYSSHITDDKVTKYTTDDANSIKAMTK
ISNWIKDGLMMNGSQYDGSADIQNFANGQTSFTILWAPAQPGIQAKLLEA
SKVDYLEIPFPSDDGKPELEYLVNGFAVFNNKDEQKVAASKTFIQFIADD
KEWGPKNVVRTGAFPVRTSYGDLYKDKRMEKIAEWTKFYSPYYNTIDGFA
EMRTLWFPMVQAVSNGDEKPEDALKAFTEKANKTIKKTQ
>SPy1370 putative deacetylase
MKKLNVILVGLLSILMLSLAIVFINRWKLNEDSQRIVLAEKKKNTSDLVI
KAVKHIKKDQKDYYYFSPIKQADDFFVDNLPVSLYKKKNSDKELILVRPK
LQSSHLRSVNTLTISKIVYQKKFFHLAKKSEKVISTYHVTDDLKPFQVKD
LVSGHLERIQEEVEKKYPDAGFNSDKYNGLKESNSLLSDGFEVKSGNLIF
DKKLTIPLTTLFDVINPDFLANSDRAAYDNYRTYKEQHPKKLVALTFDDG
PDPTTTPQVLDILAKYQAKGTFFMIGSKVVNNENLTKRVSDAGHEIANHT
WDHPNLTNLSVSEIQHQVNMTNQAIEKACGKKPRYLRPPYGATNATVQQS
SGLTQMLWTVDTRDWENHSTDGIMTNVKNQLQPGGVVLMHDIHQTTINAL
PTVMEYLKAEGYECVTVSELYAHQ
>SPy0177 putative hexulose-6-phosphate synthase
MTHIPNLQVALDHSDLQGAVKAAVAVGHEVDVIEAGTVCLLQVGSELVEV
LRSLFPEKIIVADTKCADAGGTVAKNNAKRGADWMTCICCATIPTMEAAL
KAIKEERGDRGEIQIELYGDWTYEQAQLWLDAGISQAIYHQSRDALLAGE
TWGEKDLNKVKTLIDMGFRVSVTGGLDVDTLRLFEGVDVFTFIAGRGITE
AEDPAAAARAFKDEIKRIWG
>SPy0258 putative glucose kinase
MKHYLAIDIGGTAIKYGLISETGDLLEKEEMATEAYKGGPSILEKVKGLV
KTYQDQMDLAGVAISSAGMVNPDEGEIFYAGPQIPNYAGTQFKKEIEETF
GLPCEVENDVNCAGLAEAISGSAKDYPVALCLTIGTGIGGCLLFNSQVFH
GSSHSACEVGYLHLSDGQFQDLASTTALVQEVVLAYGDDISQWDGRRIFE
QAKAGDAICIAAISKQVDYLGQGIANICYVVNPNVVVLGGGIMAQKDYLA
DKLKTALDSYLVSSLAKKTQLKFASHGNNAGILGAYYHFKQKNERSCSFI
TLEKIENNLASS
>SPy0598 putative phosphoglycerate mutase
MKLYFVRHGKTLWNLEGRFQGAGGDSPLLEEAKDEIHLLGKELAKVAFDA
VYTSDLQRAMATAAIILDAFDQQPKLYHTDQLREWRLGKLEGAKIATMAA
IYPQQMLAFRENLAQFKPDQFEAESIYQTTQRVCHLIQSFKDKHYQNVLI
VGHGANLTATIRSLLGFEPALLLAKGGLDNASLTILETKDYLTYDCLIWN
DKSFLEV
>SPy1947 putative transaldolase
MMTKKLNVKVFSDGAVLETMLKDLQTGLVTGFTTNPSLMKKAGISSYIGF
AKEVLAKITDYPVSFEVFADDLASMEKEAEKIASLGDNVYVKIPVTTSTG
ESTCPLIQKLSAKGIKLNVTAIFTIEQTQAVVDHLTARVPAIVSVFAGRI
ADTGVDPMPIMEEALRICRQKEGVELLWASPRETYNIYQADQLGVDIITC
TTDLIAKLPLQGKDLEDYSLETVQMFLKDSTSLGFKILEDYNH
>SPy1641 conserved hypothetical protein
MEIIGSLGVLVGVIVIIYLYVKEVNIIIAAPLATSLVILFNQMDPTTTLL
GKEPNQFMGALSTYILNYFAIFLLGSILAKLMETSGATTSIADYILKKVG
HDSPYKVLVAIFLISAILTYGGISLFVVMFAVLPLARSLFKKMDLAWNLI
QVPLWLGIATFTMTILPGTPAIQNVIPIQYLDTSLTAAAIPSIVGSIGCV
AFGLFYMKYCLAKSMARGETYATYAFDNEIQVKTKNLPHFLASILPLLLL
IIIALTGSLFGNDFFKKNIIFIALLAVILTASWLFRQFIPNKIAVFNLGA
SSSIAPIFATASAVAFGAVVMIVPGFTFFSDLILNIPGNPLISLAVLTSS
MSAITGSSSGALGIVMPNFAQYYLDQGLNPEMIHRVATIASNIFTIVPQS
GVFLTFLALTGLNHKNAFKETFITVSVSTFIAQVIVIAFDLFS
>SPy2051 putative PTS system, enzyme IIB
MIKIGLFCAAGFSTGMLVNNMKVAAEKKGIDCQIEAYAQGKLADYAPLLD
VALLGPQVAYTLDKSEAICKDNDIPIAVIPMADYGMLDGNKVLDLALSLV
KE
>SPy1323 putative PTS enzyme III
MTEPSNLEAIMGLIMYGGEAKGKAVEAIHAARDGQFEEAQHLLQEATNSL
NIAHKSQTHLLSQEAAGDAVELSLLMVHGQDHMMTALAFIDLAKELVTVY
DKMSAIQRGES
>SPy1709 putative PTS system, enzyme IIC component
MQPFLDIINKILGFPIQLGSGVVMLIVMTGLAMIFGVKFTKALEGGIKLA
IALTGIGAIIGILTGAFSESLQAFVKNTGISLNIIDVGWAPLATITWGSP
YTLYFLLVMLVVNIVMIVMKKTDTLDVDIFDIWHLSITGLLIMWYAARNH
LPVFVSLLIATVAVILVGVLKIINSDLMKPTFDDLLGTGPQSPMTSTHMN
YMMNPIIMVLDKIFDKVFPGLDKYDFDAAKLNKKIGFWGSKFFIGMALGF
VIGIMGDPHFTVESIKNWFGLGFTAGACLELFSLIGSWFIAAVEPLSQGI
TNFANARMHGRRFNIGLDWPFIAGRAEIWACANILAPIMLIEAVLLSKVG
NGILPLAGIIAMGMTPALLVVTRGRLIRMIIFGSLLLPLFLLSGTMIAPF
ATELAKKVGAFPAGTSAGSLITHSTLEGPMEKIFGYVIGQATTGQIASII
TLIIFVAIYLSLFAWYANQMKARNAEYAKTMK
>SPy1503 putative phosphomannomutase
MTYNEVYQEWLHNNDLSDDIKADLAAIKDNEAEIQDRFYKTLEFGTAGLR
GKLGAGTNRMNTYMVGKAAQALANTIIDHGPEAVKKGIAVSYDVRYQSRT
FAELTCSIMAANGIKAYLYKGIRPTPMCSYAIRALGCISGVMITASHNPQ
AYNGYKAYWQEGSQILDDIADQIAQHMAALTQYQEIKQMPFEKALDSGLV
TYIDESIEEAYKKEVLGLTINDTDIDKSVRVVYTPLNGVGNLPVREVLRR
RGFENVYVVPEQEMPDPDFTTVGYPNPEVPKTFAYSEKLGKAVDADILIA
TDPDCDRVALEVKNAVGDYVFLNGNKIGALLSYYIFSQRFDLGNLPANPV
LVKSIVTGDLSRAIASHYGIETVETLTGFKNICGKANEYDVTKQKNYLFG
YEESIGFCYGTFVRDKDAVSASMMIVEMAAYYKKKGQNLLDVLQTIYATF
GYYNERQIALELEGIEGQKRIARIMEDFRQTPIASVAEMALDKTIDFIDG
YQDFPKQNCLKFYLDDGSWYALRPSGTEPKIKFYLYTIGQTQENSATKLD
AIEAACRTKINQVN
>SPy1324 putative PTS system enzyme II
MKSIMLVCNAGMSTSMLVTKMQKAAQARDLEVSIWAVPVSEADNEMAANS
IDVLLLGPQVKFLLKDFKDKFEPDIKVDAINMADYGLMNGEKVLETALAM
MEE
>SPy2054 putative transcriptional regulator
MNRLERIIQLVSQKKKIDVNSLSEQLDVSKVTIRKDLDKLESKGLLRREH
GYAVLNSGDDLNVRLSYNYNIKRRIAEKAAELVQDNDTIMIESGSTCALL
AEVLCQTKRNIKVITNSCFIANYIRQYSSCQIILLGGYYQPNSEVTVGPL
LKEMISLFHVNRVFVGTDGFNKDLGFMGKDMMRSEGVRYMADAAEEVVIL
TDSSKFSKTSLVHQLSLADVNRVITDQALDKQTQELLSASGLVLDFVS
>SPy0251 putative N-acetylmannosamine-6-P epimerase
MPDKPTKEKLMEQLKGGIIVSCQALPGEPLYSETGGIMPLMAKAAQEAGA
VGIRANSVRDIKEIQAITDLPIIGIIKKDYPPQEPFITATMTEVDQLAAL
NIAVIAMDCTKRDRHDGLDIASFIRQVKEKYPNQLLMADISTFDEGLVAH
QAGIDFVGTTLSGYTPYSRQEAGPDVALIEALCKAGIAVIAEGKIHSPEE
AKKINDLGVAGIVVGGAITRPKEIAERFIEALKS
>SPy1986 putative PTS system, enzyme II, A component
MKTSFKQLFRFEFWQKFGKCLMVVIAVMPAAGLMISIGNSIPMINHDSAF
LASLGNIIAQIGWAVIVNLHLLFALAIGGSWAKERAGGAFASGLAFVLIN
RITGAFYGVSSTMLADPEAKITSLLGTQMIVKDYFTSVLESPALNTGVFV
GIIAGFVGATAYNKYYNYRKLPEVLTFFNGKRFVPFVVILRSIFVALILV
VVWPVIQSGINSFGMWIASSQDSAPILAPFLYGTLERLLLPFGLHHMLTI
PMNYTALGGTYEVMTGAAAGTKVFGQDPLWLAWVTDLVHLKGSDASAYSH
LMDSVTPARFKVGQMIGATGTLMGVALAMYRNVDADKKHTYKMMFISAAA
AVFLTGVTEPLEYLFMFAAMPLYIVYALVQGASFAMADLVNLRVHSFGNI
ELLTRTPMALKAGLGMDVINFVWVSVLFAVIMYFIADMMIKKMHLATAGR
LGNYDADILGDRNTQTRPTQVADSNSQVVQIVNLLGGAGNIDDVDACMTR
LRVTVKDPAKVGAEDDWKKAGAIGLIQKGNGVQAVYGPKADILKSDIQDL
LDSGALIPEVNMSQLTSKPTPAKDFKHVTEDVLSVADGMVLPITGVKDQV
FAAKMMGDGFAVEPTHGNIYAPVAGLVTSVFPTKHAFGLLTDNGLEVLVH
VGLDTVALNGVPFSVKVSEGQRVHAGDLLVVADLAAIKSAERETIIVVAF
TNTTEIQDVTLTSLGAQPAKTKVATVEL
>SPy1592 conserved hypothetical protein
MKKWQKIVCVTGTVLATSNLAACESKSASKDSDVKLLMYQVGDKPDNFDE
LMTIANKRIKEKTGATVDLQYIGWGDWDDKMSTIIASGENYDIAFANNYV
VNAQKGAFADLTTLMPKYAKKTYKNLDPAYIKGNTIDGKLYAFPVDANVY
AQQMLSFNKELVDKYGLDISNIKSYADAENVLKQFHEKEPNTAAFAIGQV
FSMSGDYDYPLTKTQPFAVKIDEGKPTIINQYEDESFKNNLRLMHKWYKE
GLIPTDAATNTEGYPLEGNTWFMREETQGPMDYGDTILTNAAGKDIVSRP
LTKPLKTTSQAQMANFVVSSVSKNKEKAVEVLSLLNSDPELLNGLVYGVE
GKAWEKIGDKKIKLLDGYQPKNAHGCLEYW
>SPy0501 putative multi-drug resistance efflux pump
MNWRQNLKVAWLGNFFTGASFSLVMPFMALYVENLGTPTELVEYYAGLAV
AVTALASALFAPVWGKLADRYGRKPMMLRASFVMTFTMGGLAIIPNVFWL
LILRLLTGVSAGYVPNATALIASQAPKEESGYALGTLATGVTAGALIGPL
LGGILAELLGIRQVFLLVGVILFLCSLMTAVYVKEEFKPVRRFEMIPTKV
ILKQVKSPQIMLGLFVTSMIIQISAQSVAPILSLYIRHLGQTHNLMFTSG
LVVSAMGFSSLFSSSYLGKLGDRFGNHRLLLAALCYSFIMYFSSALAQTS
FQLGVLRFAYGFGVGALMPSINSLLTKLTPKEGISRVFAYNQMFSNLGQV
IGPFIGSNVAVVLGYRSVFYVTSLIVFVNLIWSLIIFRKYIKVKDIV
>SPy1340 conserved hypothetical protein
MSTLSLDTTNKRALVAAIAASGTDDLNVMFLAFSMSSIMTDLGLSGTQGG
WIATITNLGMLVGGLLFGLLADRHHKFKVFKWTILLFSVATGLIYFTQSL
PYLYLMRFIAGIGVGGEYGVAIAIMAGIVPPEKMGRMSSLNGIAGQLGSI
SSALLAGWLAPSLGWRGLFLFGLLPILLVIWMTLAIDDQKIWDHYGQEEE
ECSQPIKINELFKTKSLTAQTLALMVMTTVQIAGYFGMMNWLPTIIQTSL
NLSVKSSSLWMVATIVGMCLGMLYFGQLLDCFGPRLIYSLFLLASSICVY
LFQFANSMASMVIGGAIVGFFVNGMFAGYGAMITRLYPHHIRSTANNVIL
NVGRALGGFSSVAIGSILDASGISMVMIFLASLYVISFGAMWSIGQLKAE
RYQQLR
>SPy1903 conserved hypothetical protein
MKILVAIDSFKGSVTSPELNTSVAQALLSVDKQLVIETRAIADGGEGSLV
ALSQTVAGRWHQVKTIDLLRRPIKVAYYRHAKQAFIESASIIGIDKITSN
SVTYAQATSYGLGLAVKDAIQKGATQIEIMLGGTGTSDGGKGFLESLNYD
FMTGRSYLDTLASPVTLLGLTDVTNPYHGPQGFAAVFGPQKGGSLSQIEE
TDQIASNFAKKVFCQTTIDLQTIPGSGAAGGLGGAIVLLGGTLTSGFSRI
AELLNLDNSLQSCDLVITGEGCLDTQSQSGKVPVAIARMAKKYQVPTIAL
CGSVKIETGLAAEDFLAVFSIQQQPISLEAAIDKTTTLSNIKILAANLML
LIAQFNK
>SPy2097 putative PTS system enzyme II
MGKFEQDAKSLLTAIGGKENIKVVTHCATRMRFVLNDNNKANVKEIEKIS
VVKGTFTNAGQFQVIIGNDVPVFYNDFTAVSSIEGVSKEAAKSAAKSNQN
ALQRVMTMLAEIFTPIIPAIIVGGLILGFRNILESVPFEFLGQQVEKGKL
VFDAAGDPVWNTIVRVSPFWSGVNHFLWLPGEAIFHFLPVGITWSVTRKM
GTTQILGIVLGICLVSPQLLNAYAVAGTPAAEIAKNWVWDFGFFTINRIG
YQAQVIPALLAGLSLAYLEIFWRKRIPEVVSMIFVPFLSLIPALILAHTV
LGPIGWTIGKGISFVVLAGLTGPVKWLFGAIFGALYAPLVITGLHHMTNA
IDTQLIADTATRTTGLWPMIALSNIAQGSAVFAYYLMNRHEEREAEISLP
AAISAYLGVTEPALFGVNVKYVYPFVAGMIGSGIAGLLSTTFNVQANSIG
VGGLPGFMAINVKYMIPFFICMAVAIVVPMFLTFFFRKSHIMTKTEDEAK
LPETPVSDAPVATAPHKTMQGTVITLTSPLTGEVKALSEAVDPVFAQGVM
GQGALLQPTEGVLVAPCDAEVSVLFPTKHAICLVTTEGLELLMHIGMDTV
NLDGQGFEALVKQGDQVKAGQTLIQFDIAAISEAGYATETPLVVTNQDVF
TVTVEGSLPRQIKVNDKLAVAVKK
>SPy1057 hypothetical protein
MKRKFLIGSHGRLASGLQSSIDILAGMGQALETIDAYVDDSDYTSQIDDF
IAGVAADEQGLIFTDLLGGSVNQKMVTAVMNSGKDNIFLITNSNLATLLS
LVFLKPGEALTKDEIVTVINESQVQLVDLVPETNSEDDFFD
>SPy0604 hypothetical protein
MNKRFKTGFLALVAMLLVACSQGTKQIQTTPSVPKADHHVRLVVKEDTNT
VDEKVSFGKGDTVLEVLKDNYEVKEKDGFITAIDGIEQDTKANKYWLFKV
NGKMADKGADQITVKDGDSIEFYQEVFN
>SPy0589 hypothetical protein
MPAPLKKHNSVEQDDSYQESQSKFRDFQEFNGQSAKLKELVFFARIASFS
LITVLFAFVLLVMNLAPMFAFLFASIISLGITSLFAKVIKSLLM
>SPy1711 putative PTS system, enzyme IIA component
MFPNILFTEARTQPELFDLVASHLEKVGYVTQEYHQALVEREAVFPTGLK
VDLKDGSDILYAAIPHTETKYCLVDQVVYVRNSQALTFKHMINPEEDCLV
TDFFFIINSQNEGQTTILSNLITFFITKGNLSYLASLKDDKQAISNYLIE
KGVFQHD
>SPy0853 putative transcriptional repressor
MAKITEENYVSLEDLMQLLNSSESTIRRDLGELEQEGRLHRVHGGAELFH
SLQEELSNQEKSVKNSHIKKAIAQRASQLIYDNDVIFIDAGTTTEFLLPF
LQAKNLTVVTNSIHHAARLVELSIETIIVGGYVKQTTDASIGNVALEQIR
QMNFDKAFLGMNGVDDSYLTTPDMEEAVIKKAVLSNAKLAYILVDGTKIG
QVSFVKVAPINDVTIITLGGSASILKQIKEKAKVIEL
>SPy1287 hypothetical protein
MFGKLLKYEFRSIGKWYFALNAFVIAIAAILSFTIKLFAQSNSDGLFGVL
TNKMLPLTLGLTFGSLIAGSLLSTLLIIIKRFSKSVFGWEGYLTLTLPVN
SHQIILSKLLASFICSVFNTIILAFAIAIVIVPMFNINELLEGFFNSFKM
DYFINMLTVLAYVLLSTFTSILLIYLSISIGQLFSNRRGLMAFIAYFILV
ILISVAATYVHSHIFNINTSADSFPFTEQKTIYLLILEQFIEMIMFYLAT
NFIIKNKLNLQ
>SPy1591 hypothetical protein
MHMGAWNTGNNKILYTQESVTDDMIAKRDQSIKDAKESPILGFTVDTKVI
KTELSNISNVMNRYKASINTGTVDPDEALPKLLADLKGAGWDKVQKEVQK
QLDDFVAKDK
>SPy1038 putative phospho-sugar mutase
MGKYFGTDGVRGEANVELTPELAFKLGRFGGYVLSQHETERPKVFVARDT
RISGEMLESALIAGLLSVGIEVYKLGVLATPGVSYLVRTEKASAGVMISA
SHNPALDNGIKFFGNDGFKLADDQELEIEALLDAPEDTLPRPSAEGLGTL
VDYPEGLRKYEKFLVTTGTDLSGMTVALDTANGAASVSARDVFLDLNAEI
AVIGEKPNGLNINDGVGSTRPEQLQELVKETGADLGLAFDGDSDRLIAVD
ETGEIVDGDRIMFIIGKYLSEKGLLAHNTIVTTVMSNLGFHKALDKQGIN
KAITAVGDRYVVEEMRSSGYNLGGEQSGHVIIMDYNTTGDGQLTAIQLAK
VMKETGKSLSELAAEVTIYPQKLVNIRVENSMKERAMEVPAIANIIAKME
DEMAGNGRILVRPSGTEPLLRVMAEAPTDAEVDYYVDTIADVVRTEIGCD
N
>SPy1094 conserved hypothetical protein
MNNRHKRRQKRKAFTLINLILLFACILGLTLIFYLYQGSNKFGLSDVSRF
VPKISLFHHKKTAKKETTKLKKTHFDSSKSQKKAHSKLTWTKQETPVKIP
ILMYHAIHVMSPEETANANLIVNPDLFDQQLQKMKDEGYYFLSPEEVYRA
LSNNELPAKKVVWLTFDDSMIDFYNVAYPILKKYDAKATNNVITGLTEMG
SAANLTLKQMKEMKQVGMSFQDHTVNHPDLEQASPDVQTTEMKDSKDYLD
KQLNQNTIAIAYPSGRYNDTTLQIAARLNYKLGVTTNEGIASAANGLLSL
NRIRILPNMSPENLLQTMEP
>SPy0629 agaD, putative PTS dependent galactosamine IID component
MTGSNKLTKKDYLKTALRAFFLQNGFNYNNYQGIGYANVIYPALKKHFGN
DKKGLYQALEDNCEFYNTNPHFLPFITSLHLVMLENNRPEEETRNIKMAL
MGPLAGIGDSLSQFCLAPLFSTIAASLASDGLVLGPILFFLAMNIILTAI
KIGSGLYGYKVGTSFIDKLSEQMAVVSRMANIVGVTVIAGLAATSVKITV
PITFAAGKVDAANTAQKFVTIQGMLDKIAPALLPALFTLLMYYLIKNKKW
TTYKLVILTVIIGVIGSWLGILA
>SPy0634 agaF, putative PTS dependent N-acetyl-galactosamine-and galactosamine IIA component
MIAIIVMGHGHFASGIVSALELIAGKQEKVTAIDFTTEMTAADVQDQLSR
ALIPEEETLVLCDLLGGTPFKVAATLMESLPNTTCNVLSGLNLAMLIEAS
FARQTAASFDDLVSGLITCSKEGIVDWKTLSQQEDGATDDELGGI
>SPy0631 agaV, putative PTS dependent N-acetyl-galactosamine-IIB component
MTQPNIIMTRVDERLIHGQGQLWVKFLNCNTVIVANDAVSEDKIQQSLMK
TVIPSSIAIRFFSIQKVIDIIHKASPAQSIFIVVKDLQDAKLLVEGGVPI
TEINIGNIHKTDDKVAITQFISLGETDKSAIRCLAHDHHVVFNTKTTPAG
NSASDVDILDYI
>SPy0630 agaW, putative PTS dependent N-acetyl-galactosamine-IIC component
MDINLLQALLIGLWTAFCFSGMLLGIYTNRCIILSFGVGIILGDLPTALS
MGAISELAYMGFGVGAGGTVPPNPIGPGIFGTLMAITSAGKVTPEAALAL
STPIAVAIQFLQTFAYTAFAGAPETAKKQLQKGNIRGFKFAANGTIWAFA
FIGLGLGLLGALSMDTLLHLVDYIPPVLLNGLTVAGKMLPAIGFAMILSV
MAKKELIPFVLIGYVCAAYLQIPTIGIAIIGIIFALNEFYNKPKQVDATT
VQGGQQDDWI
>SPy1302 amyA, putative cyclomaltodextrin glucanotransferase
MRELHIKTYKLLTKSAVLLGLISFPLTVSAADNASVTNKADFSTDTIYQI
VTDRFNDGNTSNNGKTDVFDKNDLKKYHGGDWQGIIAKIKDGYLTDMGIS
AIWISSPVENIDSIDPSNGSAAYHGYWAKDFFKTNQHFGTEADFQQLVKV
AHQHHIKVVIDFAPNHTSTAEKEGTTFKEDGALYKNGKLVGKFSDDKDKI
FNHESWTDFSTYENSIYHSMYGLADLNNINPKVDQYMKEAIDKWLDLGVD
GIRVDAVKHMSQGWQKNWLSHIYEKHNVFVFGEWFSGHTDDDYDMTTFAN
NSGMGLLDFRFANAIRQLYTGFSTFTMRDFYKVLENRDQVTNEVTDQVTF
IDNHDMERFATKVANNQTAVNQAYALLLTSRGVPNIYYGTEQYATGDKDP
NNRGDMPSFNKESQAYKVISKLAPLRKQNQALAYGTTEQRWISDHVLVFE
RKFGNHVALVAINRDQTNGYTITNAKTALPQNSYKDKLEGLLGGQELIVG
ADGTISSFELGAGQVAVWTYEGEDKTPQLGDVDASVGIAGNKITISGQGF
GNSKGQVTFGEISAEILSWSDTLITLKVPTVPANYYNISVTTADKQTSNS
YQAFEVLTDKQIPVRLLINDFKTVPGEQLYLMGDVFEMGANDAKNAVGPL
FNNTQTIAKYPNWFFDTHLPINKEIAVKLVKKDSIGNVLWTSPETYSIKT
GHEAQTITIKK
>SPy1304 amyB, putative cyclomaltodextrinase
MNVAGMLHIPDSRYCFAISQKELVIRLRVAKEDRGITVNLVHGPKYGYHE
FQEELEMSVAYTDHTHAYYETTLTLDDVRLAYIFKIEEEGQTYYFSEDGL
TTSYDFSNGFYNFFQMPYINAVDVHQVIPWTKDAVFYQIFVDRFNRGDWE
KGDSYVNMGWLEKPTPKSFAGGDLKGITEKLDYLKDLGITVIYLTPIFQS
ISNHKYDISDYYAIDPQFGTKYDLQELIDLAHKMGIKIILDAVFNHASSD
AVEFQDVLRYGKESKFFDWFMTHDEHPSMDLVNYETFAGCNYMPKWNTSN
RDVQDYLIEIGRYWIKEFCIDGWRLDVSDEVSHDFWRRFRQAVKAEKADA
ILIGENWHDAYPYLAGDQYDGIMNYAFTKACLDYFAFETMTSKQLAEKLS
NILMRNTWQVNRMNLNLLDSHDTHRFFTQVKGSKDKLLAALALLFIFMGI
PCLYYGTEVAMEGGYDPDSRRGFPWDDAERDKDFFSKVKAIIALRQQPAL
QEGAISIDYDEDCLILKRSLGEQSISLVLNNGESAYSIKEGGQILTSNGV
TKNKKQLLQDGYIVFSN
>SPy0179 araD, putative L-ribulose 5-phosphate 4-epimerase
MAKNLQEMRERVCAANKSLPQHGLVKFTWGNVSEVCRELGRIVIKPSGVD
YDLLTPENMVVTDLDGNVVEGDLNPSSDLPTHVELYKAWPEVGGIVHTHS
TEAVGWAQAGRDIPFYGTTHADYFYGPVPCARSLTKAEVDGAYEQETGNV
ILEEFSKRGLDPMAVPGIVVRNHGPFTWGKTPEQAVYHSVVLEEVARMNR
LTEQINPRVEPAPRYIMDKHYLRKHGPNAYYGQK
>SPy0574 bglA, beta-glucosidase
MGIFPKDFLWGGAVAANQVEGAFEADAKGLSVQDVLPNGGLGEWTDSPTS
DNLTLEAIDFYHRYKEDIALFAEMGFKVFRTSIAWSRIFPNGDDDQPNEA
GLQFYDDLFDELLNYGIEPLVTLSHYETPLHLAKAYNGWTDRRLIGFFER
FAQTVMERYKDKVKYWLTFNEVNSILHMPFTSGGIMTEKEKLSLQDLYQA
IHHELVASASVTKLAHEINPDVKVGCMILAMPAYPMTSDPRDILAAHAFE
NLNLLFSDIHVRGKYPSYIKSYFKENGIEIVFEDGDKELLAEHTVDFLSF
SYYMSVTQAHNPEAYTSGQGNILGGLSNPYLESSEWGWQIDPIGLRLVLN
QYYDRYQIPLFIVENGLGAKDQLVQTADGSMTVHDDYRIDYMSQHLVQVA
KAIEDGVEVMGYTSWGCIDCVSMSTAQLSKRYGFIYVDRNDDGTGQLTRY
KKKSFDWYRQVIQTNGRYLEDNFS
>SPy1328 bglA.2, putative beta-glucosidase
MKQRKHRYQFPDGFLWGSSTSGPQSEGTVPGDGKGPSNWDYWFSIESAKF
HHQIGPEKTSTFYENYKGDIALLKETGHTIFRTSIQWSRLIPEGVGEVNP
KAVTFYREVFQDIIAQGIKLIVNLYHFDLPYALQEKGGWENKATVWAYET
YAKTCFELFGDLVNTWITFNEPIVPVECGYLGYYHYPCKVDAKAAVQVAY
NTQLASSLAVKACHKLHPDHKISIVLNMTPAYPRSNAPEDVKAARIAELF
QTKSFLDPSVLGVYPAELVSILEEADLLPQYSADELEIIKNNTVDFLGVN
YYQPLRVQAPSKSQQEGDLLILDIYFEPYDMPGKKVNPHRGWEIYEPGLY
DIALNLKEHYGNIEWLVTENGMGVEGEEAFLADGQIQDDYRITFIEDHLI
QLHKALGEGANCKGYLLWTFIDCWSWLNAYKNRYGLVALDLESQKRTIKK
SGYWFKALSESNGFDK
>SPy1188 citE, putative citrate lyase, beta subunit
MERLRRTMMFVPGANAAMLRDAPLFGADSIMFDLEDSVSLKEKDTSRALV
HFALKTFDYSSVETVVRVNGLDSCGALDIEAVVLAGVNVIRLPKTETAQD
IIDVEAVIERVERENSIEVGRTRMMAAIESAEGVLNAREIAKASKRLIGI
ALGAEDYVTNMKTRRYPDGQELFFARSMILHAARAAGIAAIDTVYSDVNN
TEGFQNEVRMIKQLGFDGKSVINPRQIPLVNEIYTPTKKEIDHAKQVIWA
IREAESKGSGVISLNGKMVDKPIVERAERVIALATAAGVLSEEDI
>SPy0890 deoB, putative phosphopentomutase
MSKFNRIHLVVLDSVGIGAAPDADKFFNAGVADTDSDTLGHISEAAGLSV
PNMAKIGLGNISRPIPLKTVPTEDNPTGYVTKLEEVSLGKDTMTGHWEIM
GLNITEPFDTFWNGFPEEILTKIEEFSGRKIIREANKPYSGTAVIDDFGP
RQMETGELIVYTSADPVLQIAAHEDIIPVEELYKICEYARSITLERPALL
GRIIARPYVGDPGNFTRTANRHDYAVSPFQDTVLNKLADAGVPTYAVGKI
NDIFNGSGITNDMGHNKSNSHGIDTLIKTLQLPEFTKGFSFTNLVDFDAN
FGHRRDPEGYRDCLHEFDNRLPEIIANMKEDDLLLITADHGNDPTYAGTD
HTREYIPLLAYSVSFTGNGLIPQGHFADISATVAENFGVDTAMIGESFLS
HLK
>SPy1973 dexB, dextran glucosidase
MNNHWWHKATIYQIYPRSFKDTSGNGIGDLKGITSQLDYLQKLGITAIWL
SPVYQSPMDDNGYDISDYEAIADVFGDMADMDELLAAANERGIKIIMDLV
VNHTSDEHAWFVEARENPNSPERDYYIWRDEPNNLMSIFSGSAWELDEAS
GQYYLHLFSKKQPDLNWENAQLRQKIYDMMNFWIAKGIGGFRMDVIDLIG
KVPDLEITGNGPRLHDYLKEMNQATFGNHDVMTVGETWGATPEIARQYSR
PENKELSMVFQFEHVGLQHKPDAPKWDYAKELDVPALKAIFSKWQTELKL
GEGWNSLFWNNHDLPRVLSIWGNDSTYREKSAKALAILLHLMRGTPYIYQ
GEEIGMTNYPFKDLTEVNDIESLNYAKEAMGNGVSAARVMDSIRKVGRDN
ARTPMQWSKDTHAGFSEAKETWLPVNPNYQDINVADALADPDSIFYTYQK
LIALRKEQDWLVEADYHLLPTADKVFAYQRQLGEETYVIVVNVSDEEQVF
ATDLAGAQVIIANTDVDTVLETKHLQPWDAFCLKLKA
>SPy2096 dexS, putative dextran glucosidase
MTIDKKKVVYQIYPKSYKDTTGNGVGDLLGIIDKLPYLQELGIDMIWLNP
FYPSPQRDNGYDVSDYTAVNPDFGTMADFENLVKAAKEHQIELMLDMVLN
HCSTDHEWFQKALAGDPYYQDFFILRDQPTDWVSKFGGNAWAPFGDTGKY
YLHLFDVTQADLNWRNPHVREELAKVVNFWRDKGVKGFRFDVINLIGKDE
ELVDCPVNDGKPAYTDRPITHTYLHDLNQASFGQDDSFMTVGEMSATTID
NCLLYTAPEREELSMAFNFHHLKVDYENGQKWTIMAFDFAALRDLFHAWG
EGMSQGNGWNALFYNNHDQPRALNRFVDVTHFRNEGATMLAASIHLSRGT
PYIYMGEEIGMLDPDFDSMDDYVDVESLNAYSSLLVSGKSAEEAFAIIKA
KSRDNARTPMQWDASEHAGFTTGKPWLEVGKSYRDINVETEKEGRIFPFY
QRLIALRKELPIIAEGDYRAAFKDSQAVYAFERHLGDQCLLVLNHFYADE
VELELPPRYQHGQVLISNYEKVSICEKVILKPYQTLAILADN
>SPy0731 eno, putative enolase
MSIITDVYAREVLDSRGNPTLEVEVYTESGAFGRGMVPSGASTGEHEAVE
LRDGDKSRYLGLGTQKAVDNVNNIIAEAIIGYDVRDQQAIDRAMIALDGT
PNKGKLGANAILGVSIAVARAAADYLEVPLYTYLGGFNTKVLPTPMMNII
NGGSHSDAPIAFQEFMIMPVGAPTFKEGLRWGAEVFHALKKILKERGLVT
AVGDEGGFAPKFEGTEDGVETILKAIEAAGYEAGENGIMIGFDCASSEFY
DKERKVYDYTKFEGEGAAVRTSAEQVDYLEELVNKYPIITIEDGMDENDW
DGWKVLTERLGKRVQLVGDDFFVTNTEYLARGIKENAANSILIKVNQIGT
LTETFEAIEMAKEAGYTAVVSHRSGETEDSTIADIAVATNAGQIKTGSLS
RTDRIAKYNQLLRIEDQLGEVAQYKGIKSFYNLKK
>SPy1889 fba, putative fructose-bisphosphate aldolase
MAIVSAEKFVQAARENGYAVGGFNTNNLEWTQAILRAAEAKQAPVLIQTS
MGAAKYMGGYKVCQSLITNLVESMGITVPVAIHLDHGHYEDALECIEVGY
TSIMFDGSHLPVEENLAKTAEVVKIAHAKGVSVEAEVGTIGGEEDGIIGK
GELAPIEDAKAMVETGIDFLAAGIGNIHGPYPENWEGLALDHLEKLTAAV
PGFPIVLHGGSGIPDDQIKEAIRLGVAKVNVNTESQIAFSNATREFARNY
EANEAEYDGKKLFDPRKFLAPGMKAVQGAVEERIDVFGSANKA
>SPy0854 fruB, putative fructose-1-phosphate kinase
MIYTVTLNPSIDFIVRIDQINLGSVNRMASDDKFAGGKGINVSRILQRLD
IASTATGFLGGFTGRFIEESLSAEGVKTDFVKGDQDTRINVKIKSQEETE
LNGQGPIISQEQLEDLKTKLSQLTAEDTVVFAGSAPANLGNAVYKELLPL
VRQSGAQVVCDFEGQTLIDALAYNPLLVKPNNHELEAIFGTILTSLDDVE
TYARRLLEMGAQNVIISMAGDGALLVTKEATYFAKPIKGEVKNSVGAGDS
MVAGFTGEFMKSQNPIEALKWGVACGTATAFSDDLATIAFIKETYHKVEV
EKR
>SPy1529 glcK, glucose kinase
MSQKLLGIDLGGTTIKFGILTAAGEVQEKWAIETNILEGGKHIVPDIIAS
IKHRLDLYGLSSADFVGIGMGSPGAVDRDTNTVTGAFNLNWKETQEVGSV
VEKELGIPFAIDNDANVAALGERWVGAGENNPDVVFMTLGTGVGGGIIAD
GNLIHGVAGAGGEIGHMIVEPENGFACTCGSHGCLETVASATGVVKVARL
LAEAYEGDSAIKAAIDNGEGVTSKDIFMAAEAGDSFADSVVEKVGYYLGL
ASANISNILNPDSVVIGGGVSAAGEFLRSRIEKYFVTFTFPQVRYSTKIK
IAELGNDAGIIGAASLARQFITK
>SPy1291 glgP, putative glycogen phosphorylase
MTRFTEYVETKLGKSLTQASNEEIYLSLLNFVKEEASHKAKNSAKRKVYY
ISAEFLIGKLLSNNLINLGIYKDIKEELAAAGKSIAEVEDVELEPSLGNG
GLGRLASCFIDSIASLGINGEGVGLNYHCGLFKQVFKHNEQEAEPNFWIE
DDSWLVPTDISYDVPFKNFTLKSRLDRIDVLGYKRDTKNYLNLFDIEGVD
YGLIKDGISFDKTQIAKNLTLFLYPDDSDKNGELLRIYQQYFMVSNAAQL
IIDEAIERGSNLHDLADYAYVQINDTHPSMVIPELIRLLTEKHGFDFDEA
VAVVKNMVGYTNHTILAEALEKWPTAYLNEVVPHLVTIIEKLDALVRSEV
SDPAVQIIDESGRVHMAHMDIHFATSVNGVAALHTEILKNSELKAFYDLY
PEKFNNKTNGITFRRWLEFANQDLADYIKELIGDEYLTDATKLEKLMAFA
DDKAVHAKLAEIKFNNKLALKRYLKDNKDIELDEHSIIDTQIKRFHEYKR
QQMNALYVIHKYLEIKKGNLPKRKITVIFGGKAAPAYIIAQDIIHLILCL
SELINNDPEVSPYLNVHLVENYNVTVAEHLIPATDISEQISLASKEASGT
GNMKFMLNGALTLGTMDGANVEIAELAGMENIYTFGKDSDTIINLYATAS
YVAKDYYDNHPAIKAAVNFIISPELLAFGNEERLDRLYKELISKDWFMTL
IDLEEYIEVKEKMLADYEDQDLWMTKVVHNIAKAGFFSSDRTIEQYNEDI
WHSR
>SPy1682 glpF, putative glycerol uptake facilitator
MDIFGEFLGTALLVLLGNGVVAGVVLPKTKTHASGWIVIATGWGIAVAVA
VFISGKVAPAHLNPAVSLAFAMSGTIAWSTAIAYSLAQLLGAMVGSTLVF
LQFRPHYLAAESQADILGTFATGPAIRDTSSNLLSEIFGTFVLMLGILAF
GLYDMPAGLGTLCVGTLVIGIGLSLGGTTGYAINPARDLGPRLVHAILPL
NNKGDSDWSYAWIPVVGPIIGAVLAVLLFQVMS
>SPy1854 glpF.2, putative glycerol uptake facilitator protein
MIILFIILLPLHSSISLLKWYLLYFIIWRKPENMEMTWTVKYITEFIATA
FLIILGNGAVANVDLKGTKGHNSGWLVIAFGYGLGVMMPALMFGNVSGNH
INPAFTVGLAVSGLFPWAHVLQYVVAQLLGAIFGQLVVVMVYKPYFMKTE
NPNHVLGSFSTISSLDNGQKDSHKASYINGFLNEFVGSFVLFFGALALTK
NYFGVELVGKLIEAGYDQTTAATQISPYVTGSLAVAHIGIGFLVMVLVTS
LGGPTGPALNPARDFGPRLLHHFLPKSVLGQAKGDSKWWYAWVPVVAPIL
AAIVAVAAFKYLYIR
>SPy1429 gpmA, putative phosphoglycerate mutase
MVKLVFARHGESEWNKANLFTGWADVDLSEKGTQQAIDAGKLIKEAGIEF
DLAFTSVLTRAIKTTNLALENAGQLWVPTEKSWRLNERHYGALTGKNKAE
AAEQFCDEQVHIWRRSYDVLPPAMAKDDEYSAHKDRRYADLDPALIPDAE
NLKVTLERAMPYWEEKIAPALLDGKNVFVGAHGNSIRALVKHIKGLSDDE
IMDVEIPNFPPLVFELDEKLNIVKEYYLGGE
>SPy1730 hit, putative cell-cycle regulation histidine triad (HIT) protein
MENCIFCSIIQGDIPSSKVYEDEQVLAFLDISQTTKGHTLVIPKQHVRNL
LEMTAETASHLFARIPKIARAIQSATGATAMNIINNNEALAGQTVFHAHV
HLVPRYNEEDGISIQYTTHEPDFPVLEKLARQINQEVSS
>SPy0638 kdgK, putative 2-keto-3-deoxygluconate kinase
MSKLLLVGEPLIRVSPNQFQPLTNACEAQLFFGGSEVNIARTLGGFGLEA
RLFTALPDNPVGHAFHQFLKQSGVDMSLTAWQGHRVGLYYLENGFGCRAS
QVYYDRCGSSFSALDKDSLDLAAIFEGISHFHFSGISLALGKKTQDLIEV
LVREAKKRDICISFDLNFRSSMIAVADAKRLFSHFAQYADIIFGMEPLLL
DSDDFDMFDRKKADTTTIRERLAGLYQRYQLQAIYHTERSNDAQGSNHFK
AYAYDRQFYESCEVTTPVLQRVGSGDAFVAGLLYQLLEGNEKQRNLDFAV
ATASLKCTVAEDQLYHSVQQVEAVLANQRDIQR
>SPy0639 kgdA, putative 2-dehydro-3-deoxyphosphogluconate aldolase/4-hydroxy-2-oxoglutarate aldolase
MGKIEILTKLKANRLVLVVRGESSEEALACSLASIEGGIKTIEVTYTNPF
ASEVIGQLAERFKEDPEVLIGAGTVLDDVTARQAILAGAQFIVGPNFNRA
VALICHRYSIPYLPGCMTVNEVVTALESGVDMVKIFPGSTVGISFIRAIK
SPLPQVEVMVTGGVSSDNLKDWLAAGVDVLGIGGEFNQLASQKQYNLITK
KAAHYIKSLRQ
>SPy1708 lacA.1, putative galactose-6-phosphate isomerase
MAIILGADAHGNALKELIKSFLQEEGYDIIDVTDINSDFIDNTLAVAKAV
NEAEGRLGIMVDAYGAGPFMVATKLKGMVAAEVSDERSAYMTRGHNNARM
ITIGAEIVGPELAKNIVKGFVTGPYDGGRHQIRVDMLNKMA
>SPy1923 lacA.2, galactosidase acetyltransferase
MAIIIGADKAGQELKEVIKDYLKEGKYEVVDVSENEVRDFVDTTLAVVKE
VNASDDNLGIVIDAYGVGSFMVATKIKGMVAAEVSDERSAYMTRGHNNAR
IITLGSEISAPGIAKNIIKGFVEGKYDGGRHQVRVDMLNKMC
>SPy1707 lacB.1, putative galactose-6-phosphate isomerase
MKIAIGCDHIVTNEKMAVSDFLKSKGYDVIDCGTYDHTRTHYPIFGKKVG
EAVVNGQADLGVCICGTGVGINNAVNKVPGIRSALVRDMTTALYAKEELN
ANVIGFGGKITGELLMCDIIDAFIKAEYKETEENKKLIAKIAHLESHHAN
QEDPDFFTEFLEKWDRGEYHD
>SPy1922 lacB.2, putative galactose-6-phosphate isomerase (B subunit)
MKIAVGCDHIVTYEKIAVVDYLKSQGHKVIDCGTYDNVRTHYPIFGKKVG
EAVASGEAELGVVICGTGVGITNAVNKVPGIRSALVRDMTSAIYSKEELN
ANVIGFGGKIIGGLLMNDIIDAFLAAEYKPTEENKKWIEKMDSLQHASQD
QNNPHFFDEFLEKWDRGEYHD
>SPy1921 lacC.2, putative tagatose 6-phosphate kinase
MILTVTLNPAIDVSYPLDELKCDTVNRVVDVTKTPGGKGLNVSRVLNEFG
ETVKATGCVGGESGDFIINHLPDSILSRFYKISGDTRTCIAILHEGNQTE
ILEKGPMLSVDEIDGFTHHFKYLLNDVDVVTLSGSLPAGMPDDYYQKLIK
IANLNGKKTVLDCSGNALEAVLKGDSKPTVIKPNLEELSQLLGKEMTKDF
DALKEVLQDELFDGIEWIIVSLGADGVFAKHKDTFYNVDIPKIKIVSAVG
SGDSTVAGIASGLANDEDDRALLTKANVLGMLNAQEKTTGHVNMANYDKL
YQSIKVKEV
>SPy1704 lacD.1, putative tagatose 1,6-diphosphate aldolase
MTITANKRHYLEKVSHQGIISALAFDQRGALKQMMAAHQEGEATVTQIET
LKVLVSEELTPYASSILLDPEYGLLATKVRANQTGLLLAYEKTGYDATTT
SRLPDCLVEWSVKRLKAAGADAIKFLLYYDVDGDEQINLQKQAYIERIGS
ECTAEDIPFFLELLSYDERISDNNSAAYAKLKPHKVNGAMSVFSDKRFGV
DVLKVEVPVNMAYVEGFTEGEVHYSQAEAIKAFQDQEAASHLPYIYLSAG
VSAKLFQETLYFAAAAGAQFSGVLCGRATWAGSVPVYITKGEDEARKWLC
TEGFQNIDELNRVLEETASPWTEKI
>SPy1919 lacD.2, putative tagatose 1,6-diphosphate aldolase
MTITLTENKRKSMEKLSVDGVISALAFDQRGALKRMMAQHQTKEPTVEQI
EELKSLVSEELTPFASSILLDPEYGLPASRVRSEEAGLLLAYEKTGYDAT
TTSRLPDCLDVWSAKRIKEAGAEAVKFLLYYDIDGDQDVNEQKKAYIERI
GSECRAEDIPFYLEILTYDEKIADNASPEFAKVKAHKVNEAMKVFSKERF
GVDVLKVEVPVNMKFVEGFADGEVLFTKEEAAQAFRDQEASTDLPYIYLS
AGVSAKLFQDTLVFAAESGAKFNGVLCGRATWAGSVKVYIEEGPQAAREW
LRTEGFKNIDELNKVLDKTASPWTEKM
>SPy1917 lacE, putative PTS system, lactose-specific component IIBC
MNGLIAQIEKGKPFFEKISRNIYLRAIRDGFIAGMPVILFSSIFILIAYV
PNAWGFHWSKDIENLLMTPYNYSMGILGLFVAGTTAKALTDSMNRSLPST
NQINFISTMLAAIVGFLLMAANPAKDGGFLTGFMGTKGLLTAFIAAFITV
NVYKACVKNNVTIRMPEEVPPNISQVFKDLIPFTLSVVLLYVIELIVHTT
LGVNVAESIGKLLAPLFQAADGYVGITIIFGAFAFFWFVGIHGPSIVEPA
IAAITYANAETNLQLLQAGEHADKILTSGTQMFIVTMGGTGATLVVPFMF
MWLTKSKRNKAIGRASVVPTFFGVNEPILFGAPLVLNPIFFIPFILAPIV
NVWIFKFFIDTLGMNSFTANLPWTTPAPLGLILGTNFQVLAFILAALLIV
VDVIIYYPFLKVYDEQILAEEAAGTNSSDALKEKVAANFDTKKADAILEK
SAAKETKEITDQTNVLVLCAGGGTSGLLANALNKAAKEYGAPVTAAAGSY
GAHREILPQYQLVILAPQVASNYEDMKVETDKLDIKLAKTEGAQYIKLTR
DGQGALDFVKAQFEN
>SPy1918 lacF, putative PTS system, lactose-specific component IIA
MNREETTLLGFEIVAYAGDARSKFLEALKAAQEGDYAKAEELIAAGSDCL
NDAHNAQTSLLQKEAAGDDLAYSVTLMHGQDHLMTTILLQDLMKHMIELY
KRGAK
>SPy1916 lacG, putative phospho-beta-D-galactosidase
MTKTLPKDFIFGGATAAYQAEGATHTDGKGPVAWDKYLEDNYWYTAEPAS
DFYNRYPVDLKLSEEFGVNGIRISIAWSRIFPTGKGEVNPKGVEYYHNLF
AECHKRHVEPFVTLHHFDTPEALHSDGDFLNRENIEHFVNYAEFCFKEFS
EVNYWTTFNEIGPIGDGQYLVGKFPPGIQYDLAKVFQSHHNMMVSHARAV
KLFKDSGYSGEIGVVHALPTKYPFDANNPDDVRAAELEDIIHNKFILDAT
YLGKYSDKTMEGVNHILEVNGGELDLREEDFAALDAAKDLNDFLGINYYM
SDWMQAFDGETEIIHNGKGEKGSSKYQIKGVGRRKAPVDVPKTDWDWIIF
PQGLYDQIMRVKADYPNYKKIYITENGLGYKDEFVDNTVYDGGRIDYVKK
HLEVISDAISDGANVKGYFMWSLMDVFSWSNGYEKRYGLFYVDFETQERY
PKKSAYWYKKVAETQVIE
>SPy1712 lacR.1, putative lactose phosphotransferase system repressor protein
MLKRERLLKITEIVNEQGIVTVNDIIQTLNVSDMTVRRDLDELEKAGKLI
RIHGGAQSITMPNKKERSNIEKQTVQTKEKWELASYATQLVNDGETIFIG
PGTTLECFAEQLKNRQIRIVTNSLPVFNILQDSETIDLILIGGEYRSITG
AFVGSLASQNISSLKFAKAFISCNGIYKNDIATYSETEGEIQKLAFNNSI
EKYLLVDNQKFNAYDFFIFYHLNNIDAVVTDSQITEDVIERYSQFTQLLV
AHENKE
>SPy1924 lacR.2, putative lactose phosphotransferase system repressor protein
MKKKERHEKILDILKVDGFIKVKDIIDEMNISDMTARRDLDTLADKGLLI
RTHGGAQYLDYSSAKDEGHEKTHTEKKVLQTTEKKQIAQRAKNIIKDGET
VFIGPGTTLEHLAVELKNRNIRVITNSLPVFLILHPSTTIDLILIGGECR
EITGAFVGAIAINNLETLTFSKAFVSANAVYNNSIATYSDLEGEVQRVAL
NNAVEKILLVDSTKFESYDFYNFYQLDQVDLIVTDKNVTTDIIEKYKKFS
KIIIADK
>SPy2120 lmrP, putative integral membrane protein
MQEFLNLPKQIQLRQLVRFVTITLGSSIFPFMAMYYTTYFGTFWTGLLMM
ITSLMGFVGTLYGGHLSDALGRKKVIMIGSVGTTLGWFLTILANLPNAAI
PWLTFAGILLVEIASSFYGPAYEAMLIDLTDESNRRFVYTINYWFINIAV
MFGAGLSGLFYDHHFLALLVALLLVNVLCFGVAYYCFDETRPETHAFDHG
KGLLASFQNYRQVFHDRAFVLFTLGAIFSGSIWMQMDNYVPVHLKLYFQP
TAVLGFQVTSSKMLSLMVLTNTLLIVLFMTVVNKLTEKWKLLPQLVVGSL
LFTLGMLLSFTFTQFYAIWLSVVLLTFGEMINVSASQVLRADMMDHSQIG
SYTGFVSMAQPLGAILASLLVSVSHFTGPLGVQCLFAVIALLGIYFTVVS
AKMKKV
>SPy1301 malC, maltodextrin transport system permease
MVENQRQQKPNKAMWLSVIPGLGQLYNKQIVKGGVLLVVFFLELLEIVVL
GIPALTGLYSLGSVPMQDHSLFMLIKGAMQLITLVLFGIFHLVAMRDAKL
VAHQMNEGKKVPVTAKETLEAIYEKGFPYLLIIPAYLAMAFAIIFPVLVT
LLIAFTNYDFRHIPPYRLLDWVGLKNFLNILELSTFKTAFTSVLSWTLIW
TLAATSLQIVIGIATAVIANQSFIRGKRLFGVIFLLPWAVPAFISIMSFG
NFFNDSIGAMNVQVLPFIEKFLPFVDFGIVSWKTDPFWTKVAVIMVQGWL
GFPYIYILVSGILQAIPADLYEAATVDGATVLQKFRHITMPMIFAVAAPT
FISQYTFNFNNFSIIYLFNNGGPGTVGGGAGTTDILISWIYKLTTQTSPQ
FSMASAVTLIISVIVISVSLITFKKFKAFDMEERS
>SPy1299 malD, putative maltodextrin transport system permease
MRKTYVSISMKRKRFFTQLLTYLYLISLVIVILFPILVTVSSAFRPGNTT
AFSFHFDGPWTLSNFKTLFQDTLYLRWYWNTLIVAFFTMLIQVTVITLTG
YAYSRYNFFGRKKSLIFFLVVQMVPTMAALTAYFVMAWLFNALNQYWFLI
LIYVGGGIPMNAWLMKGYFDTVPYDLDESAKLDGSGHFRTFYQIVLPLVR
PMIAVQSLWAFMGPFGDFMLAKFLLRAQENYTVAVGLQSFITNDARNPKV
TLFAAGAILIAVPISVLFFFLQKNFVSGLTSGGTKG
>SPy1295 malF, putative maltose/maltodextrin ABC transport system (permease)
MTQSNLTPNISVIEALKRGSWDIKLSSIIMGFANFANKQFIKGILFLISE
LIFLVAFVSQIIPAIRGLVTLGTQTQGMTTKTIDGINIQVAVDGDNSMLM
LIFGLASLIFCLVFAYIYWCNLKSARNLYLFKQKGQKIPSFKEDLATLTN
GRFHMTLMAIPLIGVLLFTILPLIYMICLAFTNFDHNHLPPKSLFDWVGL
ANFGNVLSGRMAGTFFPIFSWTLIWAVFATVTNFFFGIILALLINTKGLK
WKKMWRTIFVITIAVPQFISLLIMRNLLNDEGPLNALLNKIGLINGSLPF
LSDPLWAKFSIIFVNMWIGIPFTMLIATGIIMNLPSEQIEAAEIDGASKF
QVFKSITFPQILLIMTPNLIQQFIGNINNFNVIYLLTGGGPTNSEYYQAG
TTDLLVTWLYKLTVTAADYNLASVIGILIFTVSAIFSLLAYTRTASYKEG
AAK
>SPy1296 malG, putative maltose/maltodextrin ABC transport system (permease)
MKNKRRFQLGLVYATLIILSIIWLFPIAWVILTSFRSEGTAYVNYFIPKT
FTLNHYINLFTNETFPFGKWFMNTLIVATFTCIISTFITVAIAYSLSRIK
FKFRNGFLKLALILNMFPGFMSMIAIYYILKALGLTQTLTALVLVYSSGA
ALGFYIAKGFFDTIPYSLDESAMIDGATRMDIFFKITLPLAKPIIVYTAL
LAFMGPWIDFIFAQVILGDATSKYTVAIGLFSMLQPDTINNWFMAFTAGS
VLIAVPITLLFMFMQKYYVEGITGGSVK
>SPy1292 malM, putative 4-alpha-glucanotransferase
MNKRASGILMHISSLPGKFGIGTFGKSAFEFVDFLAETKQTYWQILPLTT
TSFGDSPYQSFSAIAGNTHFIDFELLVDDELLEAADLCDITFGTNPEAVD
YAQLFQVRRPLLEKAVRAFVAEQENVCKLEAFETASSWLTDFAEFMALKE
YFNNKALQDWDDETVIKRQEDSLNNYRELLAKKITYHKVCQYFFYQQWSA
LKTYANHKGIEIIGDMPIYVSADSVEVWTMPELFKVDSDKKPLFIAGVPA
DGFSEDGQLWGNPTYNWSAHEKSNFAWWIYRIQESFKLYDQLRIDHFKGF
SDFWEIPAGDKTARNGHWASAPGIALFSAVREALGELPIIAENLGYIDEK
AEQLLASTGFPGMKILEFGLFDITSQSIDLPHYYDRNCVAYTGTHDNEVV
NGWYDNLSEEQVHFVNNYLHKHADESITKAMLRTIFASVCDTAILCIQDL
LDKDGKSRMNMPNTIGGNWQWRMLDGELNQDHKDYLIYLTDLYGRAR
>SPy1306 malX, maltose/maltodextrin-binding protein
MSWNWKKTSVLGTLSLASVLPLTACVSGGGKGVKETDGKTIVVSVDEGYV
DYIKSIKGEFEKEHKVTVKVKKEGMMDTLDKLSTDGPTGASPDVFLAPFD
RVGGLGTEGQIAEVTLGNSKEFDDTVKKLVTIDGKTYGAPDVIETLVTYY
NKDLVPQAPKSFTELEVLQKDSKFAFASEPGKSVGFLAKWTDFYYGYGLI
AGYGGYIFGDKGTKPSDLGLGNDGTVEGLNYAKQWYGTWPQGMQDTKKAG
DFITEQFISKKAGVIIDGPWAASSFKDAGVNFGVMEIPTLTNGKKYQPFA
GGKAWVISNYSKGKTTAQKFLDYVTNAENQKRFYDKTQEIPANLTARNYA
SKEGNELTKAVISQFESAQPMPNIPEMAEVWEPGANMFFNVASGKEEASK
AAKEAAKTIKEAIEQKYAE
>SPy1738 manL, mannose-specific phosphotransferase system component IIAB
MGIGIIIASHGKFAEGIHQSGSMIFGEQEKVQVVTFMPNEGPDDLYGHFN
NAIQQFDADDEILVLADLWSGSPFNQASRVAGENPDRKMAIITGLNLPML
IQAYTERLMDAGAGVEQVAANIIKESKDGIKALPEDLNPVEETAATEKVV
NALQGAIPAGTVIGDGKLKINLARVDTRLLHGQVATAWTPASKADRIIVA
SDEVAQDDLRKQLIKQAAPGGVKANVVPISKLIEASKDPRFGNTHALILF
QTPQDALRAVEGGVEINELNVGSMAHSTGKTMVNNVLSMDKEDVATFEKL
RDLGVTFDVRKVPNDSKKNLFELIQKTNIK
>SPy1739 manM, putative mannose-specific phosphotransferase system component IIC
MSDISIISAILVVIIAFFAGLEGILDQFQMHQPLVACTLIGLVTGHLEAG
VILGGTLQMLALGWANIGAAVAPDAALASVAAAIIMVKSGDFTQKGITFA
YSTAIPLAVAGLFLTMIVRTLSTALVHAGDKAAAEGNFAGIERFHFIALL
LQGLRIAVPAALLVAVPTSAVQSVLNAMPNWLNEGMQIGGAMVVAVGYAM
VINMMATREVWPFFALGFALAAISQLTLIAMGVIGVAIAFIYLNLSKKGG
NGGNAAGSADPIGDILEDY
>SPy1740 manN, putative mannose-specific phosphotransferase system component IID
MTEQIKLTKSDRQRVWWRSQFLQGSWNYERMQNMGWAYALIPALKKLYTS
PEDRAAALERHMEFFNTHPYVAAPIIGVTLALEEERANGTPIDDKAIQGV
KIGMMGPLAGIGDPVFWFTIRPILGALGASLASTGNIVGPLLFFFGWNLI
RMAFLWYTQEFGYKAGSEITKDMSGGILQDITKGASILGMFILAVLVQRW
VSINFTIDLPGKQLSDGAYVVFPDGAVKGAELKTILANAIGGMSLDKVQA
QTLQGQLDSLIPGLAGLLLTFLCMWLLKKKVSPIAIIIGLFAFGILAHLA
GIM
>SPy2048 mipB, putative transaldolase-like protein
MEYMLDTLDLEAIKKWHHILPLAGVTSNPSIAKKEGEIDFFERIREVRAI
IGDKASIHVQVIAQDYEGILKDAAEIRRQCGDSVYVKVPVTTEGLAAIKT
LKAEGYHITATAIYTTFQGLLAIEAGADYLAPYYNRMENLNIDPEAVIEQ
LAEAINRENANSKILAASFKNVAQVNKSFALGAQAITAGPDVFEAGFAMP
SIQKAVDDFGKDWEAIHHRKSI
>SPy1976 msmK, multiple sugar-binding ABC transport system (ATP-binding protein)
MVELNLNHIYKKYPNTTHYAVEDFDLDIKDKEFIVFVGPSGCGKSTTLRM
IAGLEDISEGELKIGGEVVNDKSPKDRDIAMVFQNYALYPHMTVYDNMAF
GLKLRKYKKDDIDRRVKEAAQILGLTEFLERKPADLSGGQRQRVAMGRAI
VRDAKVFLMDEPLSNLDAKLRVSMRAEIAKIHRRIGSTTIYVTHDQTEAM
TLADRIVIMSATKNPQGNGTIGKIEQVGSPQELYNLPANKFVAGFIGSPA
MNFFEVEVKDGRIVSEDGLDIAIPEGQAKMLEAAGYKGEKVTFGIRPEDI
SSRQIVHDTYPSATVTAEVLVSELLGSETMLYVKLGQTEFASRVDARDFH
SPGEQVSLTFNVAKGHFFDRDTEQAIR
>SPy1694 nagA, putative N-acetylglucosamine-6-phosphate deacetylase
MTCYLKADCFYYPTEVRPAGYLSLHDGVFGEWTEIVPADAQIIDYTGYQI
APGLVDTHIHGYAGADVMDNSAQGIHQMSEGLLATGVTSFLPTTLTSTFE
QLEKVSGTIASVADQVKGAKIQGIYFEGPYFTEEYKGAQNPSYMKTPRLE
EFDAWQKAAKGLIKKIALAPERDGVKEFVSAVTKQGVTVALGHSNGTYQE
AKEAVQAGASVWVHAYNGMRGLTHREPGMVGAVYNLPNTYAELICDGHHV
SPIACDILMQQKGHDHVAMITDCMRAGGSPDGDYLLGEFSVVVANGTARL
KESGNLAGSILKLKDGLRNVVAWGIATPAEAIHMATYVPAVSVGIDDVCG
QIKAGHAADFIVLDKDLTLVATYLNGQKAFDA
>SPy1399 nagB, putative N-acetylglucosamine-6-phosphate isomerase
MKIIRVQDQIEGGKIAFTLLKDSLAKGAKTLGLATGSSPISFYQEMVKSP
LDFSDLTSINLDEYVGLSVESDQSYDYFMRQNLFNAKPFKKNYLPNGLAT
DVEAEAKRYNQIIAEHPIDFQVLGIGRNGHIGFNEPGTSFEEETHVVDLQ
ESTIEANSRFFTSIEDVPKQAISMGIASIMKSEMIVLLAFGQEKADAIKG
MVFGPITEHLPASILQKHDHVIVIVDEAAASQLD
>SPy1856 norA, putative antibiotic resistance protein NorA
MPFDSNTYIIPLKYIIFCFFCKMFMKIERSSFSMEEKLFNKHFVAITVIN
FIVYMVYYLFTVIIAFVATRELGAQTSQAGLATGIYILGTLLARLIFGKQ
LEVFGRRLVLRGGAIFYLLTTLAYFYMPTISMMYLVRFLNGFGYGVVSTA
TNTIVTAYIPARKRGEGINFYGLSTSLAAAIGPFVGTFMLDNLHIDFRMI
IVLCSVLIGCVVVGAFAFPVKNMSLNAEQLAKTKSWTVDSFIEKKALFIT
AIAFLMGIAYASVLGFQKLYTSEIHLTTVGAYFFVVYALIITITRPAMGR
LMDAKGDKWVLYPSYLFLAMGLFLLGSVSSGGSYLLSGALIGFGYGTFMS
CGQAASIQGVDEHRFNTAMSTYMIGLDLGLGAGPYLLGLIKDLALGSGVA
SFRHLFWLAAVIPLICTLLYLLKTKTRQVVS
>SPy0115 pepA, putative glutamyl-aminopeptidase
MTDLFSKIKEVTELDGIAGYEHSVRDYLRTKITPLVDRVETDGLGGIFGI
RDSKAEKAPRILVAAHMDEVGFMVSDIKVDGTLRVVGIGGWNPLVVSSQR
FTLYTRTGQVIPLISGSVPPHFLRGANGSASLPHIEDIVFDGGFTDKAEA
ERFGITPGDIIIPQSETILTANQKNIISKAWDNRYGVLMITEMLEALKGQ
DLNNTLIAGANVQEEVGLRGAHVSTTKFDPELFFAVDCSPAGDIYGNPGT
IGDGTLLRFYDPGHVMLKDMRDFLLTTAEEAGVNFQYYCGKGGTDAGAAH
LQNGGVPSTTIGVCARYIHSHQTLYAMDDFVEAQAFLQAIIKKLDRSTVD
LIKCY
>SPy1283 pfk, putative 6-phosphofructokinase
MKRIAVLTSGGDAPGMNAAIRAVVRKAISEGMEVYGINRGYAGMVDGDIF
PLGSKEVGDKISRGGTFLYSARYPEFAQLEGQLAGIEQLKKHGIEGVVVI
GGDGSYHGAMRLTEHGFPAVGIPGTIDNDIAGTDYTIGFDTAVNTAVEAI
DKLRDTSSSHGRTFVVEVMGRNAGDIALWAGIASGADQIIVPEEEFDIEK
VASTIQYDFEHKGKNHHIIVLAEGVMSGEAFAQKLKEAGDKSDLRVTNLG
HILRGGSPTARDRVIASWMGSHAVELLKDGKGGLAVGIHNEELVESPILG
TAEEGALFSLTEEGKIIVNNPHKARLDFAALNRSLSQ
>SPy0215 pgi, glucose-6-phosphate isomerase
MSHITFDYSKVLESFAGQHEIDFLQGQVTEADKLLREGTGPGSDFLGWLD
LPENYDKDEFARILTAAEKIKADSEVLVVIGIGGSYLGAKAAIDFLNHHF
ANLQTAKERKAPQILYAGNSISSTYLADLVEYVQDKEFSVNVISKSGTTT
EPAIAFRVFKELLVKKYGQEEANKRIYATTDKVKGAVKVEADANNWETFV
VPDNVGGRFSVLTAVGLLPIAASGADITALMEGANAARKDLSSDKISENI
AYQYAAVRNVLYRKGYITEILANYEPSLQYFGEWWKQLAGESEGKDQKGI
YPTSANFSTDLHSLGQFIQEGYRNLFETVIRVDNPRKNVIIPELAEDLDG
LGYLQGKDVDFVNKKATDGVLLAHTDGGVPNMFVTLPAQDEFTLGYTIYF
FELAIAVSGYMNAVNPFDQPGVEAYKRNMFALLGKPGFEALSAELNARL
>SPy1881 pgk, putative phosphoglycerate kinase
MAKLTVKDVDLKGKKVLVRVDFNVPLKDGVITNDNRITAALPTIKYIIEQ
GGRAILFSHLGRVKEEADKEGKSLAPVAADLAAKLGQDVVFPGVTRGSKL
EEAINALEDGQVLLVENTRFEDVDGKKESKNDEELGKYWASLGDGIFVND
AFGTAHRAHASNVGISANVEKAVAGFLLENEIAYIQEAVETPERPFVAIL
GGSKVSDKIGVIENLLEKADKVLIGGGMTYTFYKAQGIEIGNSLVEEDKL
DVAKDLLEKSNGKLILPVDSKEANAFAGYTEVRDTEGEAVSEGFLGLDIG
PKSIAEFDQALTGAKTVVWNGPMGVFENPDFQAGTIGVMDAIVKQPGVKS
IIGGGDSAAAAINLGRADKFSWISTGGGASMELLEGKVLPGLAALTEK
>SPy1224 pgmA, putative phosphoglucomutase
MTYTENFQKWLDFEQLPDYLRQELLSMDEKTKEDAFYTNLEFGTAGMRGY
IGAGTNRINIYVVRQATEGLAKLIETKGEEAKKRGVAIAYDSRHFSPEFA
FESAQVLAQHGIKSYVFEALRPTPELSFAVRHLNAYAGIMVTASHNPAPF
NGYKVYGQDGGQLPPADADALTDFIRAIENPFAVELADLDENKSSGLIQV
IGEDVDMEYLREVKDVNINQDLINNFGKDMKIVYTPLHGTGEMLTRRALA
QAGFESVVVVESQAKADPDFSTVKSPNPESQAAFALAEELGREVEADVLV
ATDPDADRLGVEIRQPDGSYKNLSGNQIGAIIAKYILEAHKTAGTLPENA
ALAKSIVSTELVTKIAESYGATMFNVLTGFKFIAEKIQEFEEKHNHTYMF
GFEESFGYLIKPFVRDKDAIQAVLLVAEIAAYYRSRGLTLADGIDEIYKE
YGYFAEKTISVTLSGVDGAAEIKKIMDKFRENGPKQFNNTDIVLLEDFQK
QTATKNDGTISNLTTPPSNVLKYTLADDSWIAVRPSGTEPKIKFYIATIG
DTLDIAQEKIANIETEINTFVG
>SPy0274 plr, glyceraldehyde-3-phosphate dehydrogenase, plasmin receptor
MVVKVGINGFGRIGRLAFRRIQNIEGVEVTRINDLTDPNMLAHLLKYDTT
QGRFDGTVEVKEGGFEVNGNFIKVSAERDPENIDWATDGVEIVLEATGFF
AKKEAAEKHLHANGAKKVVITAPGGNDVKTVVFNTNHDILDGTETVISGA
SCTTNCLAPMAKALHDAFGIQKGLMTTIHAYTGDQMILDGPHRGGDLRRA
RAGAANIVPNSTGAAKAIGLVIPELNGKLDGAAQRVPVPTGSVTELVVTL
DKNVSVDEINAAMKAASNDSFGYTEDPIVSSDIVGVSYGSLFDATQTKVM
EVDGSQLVKVVSWYDNEMSYTAQLVRTLEYFAKIAK
>SPy1810 pmi, putative mannose-6-phosphate isomerase
MSEPLFLKSTMHDRIWGGTKLRDVFAYNIPSDTTGEYWAISAHPNGVSTV
TNGRYQGQPLNTLYAQEPALFGNPKEEVFPLLTKILDANDWLSVQVHPDD
AYGREHEGELGKTECWYIISAEEGSEIVYGHQAKSKEDLRAMIEAGAWDD
LLTRVPVKAGDFFYVPSGTMHAIGKGILILETQQSSDTTYRVYDFDRKDV
NGNLRDLHIEKSIDVLTIGKPENSVPATMVLDNMVATTLVSTPFFTVYKW
VTSQMVDMKQAAPYLLVSVLKGQGKLYVDQKAYELEKGMHFILPNDVKSW
SFDGQLEMIVSHPNQLV
>SPy1372 pstI, putative phosphoenolpyruvate:sugar phosphotransferase system enzyme I
MTEMLKGIAASDGVAVAKAYLLVQPDLSFETVTVADTNAEEARLDVALQA
AQDELSVIRENAVESLGEEAAAVFDAHLMVLADPEMISQVKETIRAKQTN
AETGLKEVTDMFITIFEGMEDNPYMQERAADIRDVAKRVLAHLLGVKLPN
PATINEESIVIAHDLTPSDTAQLNKQFVKAFVTNIGGRTSHSAIMARTLE
IAAVLGTNDITKRVKDGDVIAVNGITGEVIIDPSEDQVLAFKEAGAAYAK
QKAEWSLLKDAHTETADGKHFELAANIGTPKDVEGVNDNGAEAVGLYRTE
FLYMDSQDFPTEDEQYEAYKAVLEGMNGKPVVVRTMDIGGDKELPYFDLP
KEMNPFLGFRALRISISETGDAMFRTQMRALLRASVHGQLRIMFPMVALL
KEFRAAKAVFDEEKANLLAEGVAVADDIQVGIMIEIPAAAMLADQFAKEV
DFFSIGTNDLIQYTMAADRMNEQVSYLYQPYNPSILRLINNVIKAAHAEG
KWAGMCGEMAGDQQAVPLLVGMGLDEFSMSATSVLRTRSLMKKLDSAKME
EYANRALTECSTAEEVLELSKEYVSED
>SPy1373 ptsH, putative phosphotransferase system phosphohistidine-containing protein
MASKDFHIVAETGIHARPATLLVQTASKFASDITLDYKGKAVNLKSIMGV
MSLGVGQGADVTISAEGADAEDAIAAIEETMTKEGLA
>SPy1972 pulA, putative pullulanase
MKKKVNQGSKRYQYLLKKWGIGFVIAATGTVVLGCTPSILTHQVAAKTIV
GLARDEAQQGDGNAKSGDGLQSSSKEAKPVLDSSSANPASIAEHHLRMHF
KTLPAGESLGSLGLWVWGDVDQPSKDWPNGAITMTKAKKDDYGYYLDVPL
AAKHRQQVSYLINNKAGENLSKDQHISLLTPKMNEVWIDENYHAHAYRPL
KKGYLRINYHNQSGHYDNLAVWTFKDVKTPTTDWPNGLDLSHKGHYGAYV
DVPLKEGANEIGFLILDKSKTGDAIKVQPKDYLFKELDNHTQVFVKDTDP
KVYNNPYYIDQVSLKGAEQTTPNEIKAIFTTLDGLDEDAVKQNIKITDKA
GKTVAIDELTLDRDKSVMTLKGDFKAQGAVYTVTFGEVSQVARQSWQLKD
KLYAYDGELGATLAKDGSVDLALWSPSADTVKVVVYDKQDQTRVVGQADL
TKSDKGVWRAHLTSDSVKGISDYTGYYYLYEITRGQEKVMVLDPYAKSLA
AWNDATATDDIKTAKAAFIDPSKLGPTGLDFAKINNFKKREDAIIYEAHV
RDFTSDKALEGKLTHPFGTFSAFVEQLDYLKDLGVTHVQLLPVLSYFYAN
ELDKSRSTAYTSSDNNYNWGYDPQHYFALSGMYSANPNDPALRIAELKNL
VNEIHKRGMGVIFDVVYNHTARTYLFEDLEPNYYHFMNADGTARESFGGG
RLGTTHAMSRRILVDSITYLTREFKVDGFRFDMMGDHDAAAIEQAFKAAK
AINPNTIMIGEGWRTYQGDEGKKEIAADQDWMKATNTVGVFSDDIRNTLK
SGFPNEGTAAFITGGAKNLEGLFKTIKAQPGNFEADAPGDVVQYIAAHDN
LTLHDVIAKSINKDPKVAEEEIHKRIRLGNTMILTAQGTAFIHSGQEYGR
TKQLLNPDYKTKASDDKVPNKATLIDAVAQYPYFIHDSYDSSDAVNHFDW
AKATDSIAHPISNQTKAYTQGLIALRRSTDAFTKATKAEVDRDVTLITQA
GQDGIQQEDLIMGYQTVASNGDRYAVFVNADNKTRKVVLPQAYRYLLGAQ
VLVDAEQAGVTAIAKPKGVQFTKEGLTIEGLTALVLKVSSKTANPSQQKS
QTDNHQTKTPDGSKDLDKSLMTRPKRAKTNQKLPKTGEASSKGLLAAGIA
LLLLAISLLMKRQKD
>SPy1282 pyk, putative pyruvate kinase
MNKRVKIVATLGPAVEIRGGKKYGEDGYWAGQLDVEESAKKIAELIEAGA
NVFRFNFSHGDHKEQGDRMATVRLAEEIARQKVGFLLDTKGPEMRTELFA
DDAKEFSYVTGEKIRVATTQGIQSTRDVIALNVAGSLDIYDEVEVGHTIL
IDDGKLGLKVIDKDIATRQFIVEVENDGIIAKQKGVNIPNTKIPFPALAE
RDNADIRFGLEQGLNFIAISFVRTAKDVEEVREICRETGNDHVQLFAKIE
NQQGIDNLDEIIEAADGIMIARGDMGIEVPFEMVPVFQKMIITKVNAAGK
AVITATNMLETMTEKPRATRSEVSDVFNAVIDGTDATMLSGESANGKYPV
ESVRTMATIDRNAQTLLNEYGRLDSSAFPRTNKTDVIASAVKDATHSMDI
KLVVTITETGNTARAISKFRPDADILAVTFDEKVQRALMINWGVIPVLAE
KPASTDDMFEVAERVAVEAGLVQSGDNIVIVAGVPVGTGGTNTMRVRTVK
>SPy0789 rgpCc, putative ABC-transporter (permease protein)-possibly involved in cell wall localization and side chain formation of rhamnose-glucose polysaccharide
MVKTDFKLRYQGSAIGYLWSILKPLMMFTIMYLVFIRFLRLGGNVPHFPV
ALLLANVIWSFFSEATSMGMVSIVSRGDLLRKLNFSKHIIVFSAVLGALI
NFLINLVVVLIFALINGVTISGYAYLSLFLFIELVVLVLGIALLLSNVFV
YYRDLAQVWEVLLQAGMYATPIIYPITFVLDSHPLAAKLLMLNPVAQMIQ
DFRYLLIDRANVTIWQMSTNWFYIVIPYLVPFVILFIGIFVFKKNADRFA
EII
>SPy0790 rgpDc, ABC-transporter (ATP-binding protein)-possibly involved in cell wall localization and side chain formation of rhamnose-glucose polysaccharide
MINREIAVKVQHVSKTFKLPTEATKSFRTTLVNRLRGIKGFTEQHVLKDI
NFDVYKGDFFGIVGRNGSGKSTLLKIISQIYVPEKGQVTVDGKMVSFIEL
GVGFNPELTGRENVYMNGAMLGFTKDEVDDMYNDIVDFAELHHFMNQKLK
NYSSGMQVRLAFSVAIKAQGDVLILDEVLAVGDEAFQRKCNDYFMERKDS
GKTTILVTHDMGAVKKYCNRAVLIEDGLVKAYGEPFDVANQYSVDNTETA
EDAMNAEKISVSDIAKDLKVSLISNPRITPNDTITFEVSYEVLKDDFTYI
AFSLTDIDRNIWVYNDNSLDYPTQGIGRKCISYQCQLSQLNDIKLKLEVT
VRDKNGQMLLFSTAEQSPQIVIQRNDIDQDDLSALDSASGLYQRNGKWVF
H
>SPy0264 rpe, putative ribulose-phosphate 3-epimerase
MSTLKIAPSILAADYANFASELARIEETDAEYVHIDIMDGQFVPNISFGA
DVVASMRKHSKLVFDCHLMVVDPERYVEAFAQAGADIMTIHTESTRHIHG
ALQKIKAAGMKAGVVINPGTPATALEPLLDLVDQVLIMTVNPGFGGQAFI
PECLEKVATVAKWRDEKGLSFDIEVDGGVDNKTIRACYEAGANVFVAGSY
LFKASDLVSQVQTLRTALNV
>SPy0889 rpiA, putative ribose 5-phosphate isomerase
MEALKKIAGVTAAQYVTDGMTIGLGTGSTAYYFVEEIGRRVKQEGLQVVG
VTTSSVTSKQAEVLGIPLKSIDDIDSIDLTVDGADEVDKNFNGIKGGGAA
LLMEKIVATPTKEYIWVVDASKMVEHLGAFKLPVEVVQYGADRLFRVFEK
AGYKPSFRMKGDSRLVTDMQNYIIDLDLGCIKDPVAFGHLLDGTVGVVEH
GLFNGMVDKVIVASKDGVTVLEAPTAG
>SPy1815 scrA, putative sucrose-specific PTS permease, enzyme II
MDNRQIAAEVIEALGGRENVRSVAHCATRLRVMVYDEGKIDKEKAEAIDK
VKGAFFNSGQYQMIFGTGTVNNIYDEVVALGLPTSSTSEQKAEAGKHGNI
FQRAIRTFGDVFVPIIPAIVATGLFMGVRGLVTQPAIMDLFGVHEYGENF
LMYTRILTDTAFVYLPALVAWSAFRVFGGNPIIGIVLGLMLVSNELPNAW
VVASGGDVKPLTFFGFVPVVGYQGTVLPAFFVGLVGAKLEKWLHKKVPEA
LDLLVTPFLTFAIMSTLGLFVIGPVFHSLENLVLAGTQAVLHLPFGIAGL
IVGGIQQLIVVTGIHHIFNFLEAQLIANTGKDPFNAYLTAATAAQAGATL
AVAVKTKSTKLKGLAFPSTLSALLGITEPAIFGVNLRYPKVFVSGLIGGA
LGGWVAGLFGIAGTGFGITVLPGTLLYLNGQLLQYLVTMLVGLGVAFAIA
YTWGYQDRETLPLPAVEVDQTADQPALAEETLYSPLNGTVVDLSAVSDPV
FSSGAMGQGLAIKPEDNTLYSPVDGKVEIVFETGHAYAITSSQGAEVLLH
IGIDTESMAGDGFESLVAVGQAVKKGDLLGHFDPSKIAEAGLDDTTMMIV
SNIADYQSVDILAQGHVLRW
>SPy1816 scrB, putative sucrose-6-phosphate hydrolase
MDLPQAIRYRPYKEWSSKDYQAITEKMAQSPWHSQFHVEPKTGLLNDPNG
FSYFNGRYHLFYQNWPYGAAHGLKQWVHMTSTDLVHFTETRSRLLPDHAH
DSHGAYSGSAYAIDDKLFLFYTGNVRDANWVRTPLQVGAWMDKQGNISKI
PQVLIEQPDDVTEHFRDPQLFSYQGQFYAIIGAQGLDGKGKIKLYKAVDN
HVDNWRFIADLDFDDSGTEYMIECPNLVFVDDKPVLIFSPQGLAKADLDY
QNIYPNTYKIFESFNPETGQLLGGGALQNLDFGFEAYATQAFSSPDGRVL
AVSWIGLPDIDYPTDRYDYQGALSLVKELRIKDGILYQTPVSALQNLRGP
AELFHNKIDSSNCYELELTIPGQKKLDLLLFADQKGNGLRLKVDTTKGQL
SIDRSRAGVQYAQDYGTVRSCQIPQGHVTLNVYVDNSILEIFINQGQKVL
TSRVFPTHGQTGIQVVEGQAFGHYYEMRY
>SPy1811 scrK, putative fructokinase
MGKLYGSIEAGGTKFVCAVGDEEFTVVDKTQFPTTTPEETIARTIAYFKA
FEADLAGMAIGSFGPIDIDPSSETYGYITTTPKSGWANVDLLGQLSAAFK
IPFDVTTDVNSSAYGEVLARPGVESLVYYTIGTGIGAGAIQHGHFIGGLG
HTEAGHTYVMPHPDDMAKGFLGVCPFHKGCLEGMAAGPSIEARTGVRGER
LDQEADVWDIQAFYIAQAALQATMLYRPQVIVFGGGVMAQEHMVLRVHDK
FTALLSGYLPVPDLTDYIVTPAVADNGSATLGNFALAKLAAQGK
>SPy1676 tkt, putative transketolase
MMSKLVFFWQNREKEFRDFGGFSEKSVYFCDTIDNRKRLILVVINREVLL
MTFDAIDQLAVNTVRTLSMDAIQAANSGHPGLPMGAAPMAYVLWNHFMNI
NPKTSRNWSNRDRFILSAGHGSAMLYSLLHLAGYDLSVEDLKNFRQWGSK
TPGHPEVNHTDGVEATTGPLGQGIANAVGMAMAEAHLAAKFNKPGFDIVD
HYTFALNGDGDLMEGVSQEAASMAGHLKLGKLVLLYDSNDISLDGPTSMA
FTEDVKGRFEAYGWQHILVKDGNDLEEIAAAIEAAKAETEKPTIIEVKTI
IGFGAEKQGTSAVHGAPLGAEGIAFAKKAYQWTHQDFEVPAEVTERFAQG
LQARGEKAEQAWNDLFAAYEAEYPELAAEYQKAFTNEAAQVELEAHELGS
SMASRVSSQQAIQQISEQVASFWGGSADLSASNNTMVKAETDFQPGHYEG
RNIWFGVREFAMAAAMNGIALHGGTRVYGGTFFVFSNYLLPAVRMAALQN
LPTVYVMTHDSIAVGEDGPTHEPIEQLASVRSMPNLNVIRPADGNETNAA
WKRAIAETDRPTMLVLTRQNLPVLEGTKELAEDGLSKGAYILSEAKGDLD
GILIATGSEVKLAMDTQEALEAEGIHVRVVSMPSQNIFDEQSAEYKESIL
PAAVTKRLAIEAGSSFGWAKYVGLSGKTLTIDTWGASAPGNRIFEEYGFT
VANATELYKSL
>SPy0613 tpi, putative triosephosphate isomerase
MSRKPIIAGNWKMNKNPQEAKAFVEAVASKLPSTDLVDVAVAAPAVDLVT
TIEAAKDSVLKVAAQNCYFENTGAFTGETSPKVLAEMGADYVVIGHSERR
DYFHETDEDINKKAKAIFANGLTPIVCCGESLETYEAGKAVEFVGAQVSA
ALAGLSAEQVASLVLAYEPIWAIGTGKSATQDDAQNMCKAVRDVVAADFG
QEVADKVRVQYGGSVKPENVKDYMACPDVDGALVGGASLEADSFLALLDF
LN